,condition,gene,fold,percent,pathway,cell type
1,ALS_A,NF1,0.7,36,"pyruvate metabolism, cancer pathways",smooth
2,ALS_A,UEVLD,0.2,96,"Wnt signalling, apoptosis",skeletal
3,ALS_A,CDC37L1,0.7,89,"cancer pathways, fatty acid degradation",skeletal
4,ALS_A,HOXD10,-0.1,54,"pyruvate metabolism, Wnt signalling",cardiac
5,ALS_A,NNT,-0.1,33,"apoptosis, propanoate metabolism",smooth
6,ALS_A,HUWE1,0.5,54,"Wnt signalling, propanoate metabolism",cardiac
7,ALS_A,GJA5,NA,58,"propanoate metabolism, propanoate metabolism",skeletal
8,ALS_A,SPCS3,0.6,14,"Wnt signalling, pyruvate metabolism",cardiac
9,ALS_A,DOT1L,-0.2,37,"Wnt signalling, apoptosis",skeletal
10,ALS_A,ATP6V0E1,NA,27,"Wnt signalling, citrate cycle",cardiac
11,ALS_A,XAF1,-0.2,100,"cancer pathways, apoptosis",cardiac
12,ALS_A,MAFG,-0.8,64,"MAPK, pyruvate metabolism",smooth
13,ALS_A,AAK1,NA,3,"MAPK, propanoate metabolism",cardiac
14,ALS_A,TM2D3,0.5,36,"Wnt signalling, cancer pathways",skeletal
15,ALS_A,SSR3,0.1,18,"focal adhesion, propanoate metabolism",cardiac
16,ALS_A,ZNF281,-0.3,36,"propanoate metabolism, fatty acid degradation",skeletal
17,ALS_A,JAM2,0.2,56,"synthesis and degradation of ketone bodies, pyruvate metabolism",skeletal
18,ALS_A,CDC23,0.5,47,"MAPK, pyruvate metabolism",smooth
19,ALS_A,PLN,-0.6,67,"synthesis and degradation of ketone bodies, fatty acid degradation",smooth
20,ALS_A,PGP,-0.2,89,"citrate cycle, apoptosis",skeletal
21,ALS_A,HYI,-0.2,12,"citrate cycle, apoptosis",cardiac
22,ALS_A,IMPACT,0.3,89,"apoptosis, apoptosis",smooth
23,ALS_A,C2orf49,0.2,9,"cancer pathways, focal adhesion",skeletal
24,ALS_A,HDAC11,-0.3,85,"pyruvate metabolism, cancer pathways",skeletal
25,ALS_A,CCN4,-0.3,68,"Wnt signalling, MAPK",skeletal
26,ALS_A,MKLN1,0.1,86,"synthesis and degradation of ketone bodies, apoptosis",smooth
27,ALS_A,GPRC5B,0.3,4,"fatty acid degradation, fatty acid degradation",skeletal
28,ALS_A,RPS6KB1,0.3,48,"pyruvate metabolism, apoptosis",smooth
29,ALS_A,PSMA3,0.6,70,"cancer pathways, pyruvate metabolism",skeletal
30,ALS_A,JARID2,-0.1,92,"fatty acid degradation, cancer pathways",skeletal
31,ALS_A,ODF2,-0.3,76,"pyruvate metabolism, fatty acid degradation",smooth
32,ALS_A,MON2,0.3,69,"Wnt signalling, pyruvate metabolism",smooth
33,ALS_A,PDLIM2,-0.4,1,"cancer pathways, MAPK",skeletal
34,ALS_A,WAC,0.7,19,"fatty acid degradation, citrate cycle",skeletal
35,ALS_A,FLCN,NA,3,"synthesis and degradation of ketone bodies, Wnt signalling",smooth
36,ALS_A,ATF6,-0.1,94,"propanoate metabolism, fatty acid degradation",smooth
37,ALS_A,TRAFD1,NA,28,"fatty acid degradation, pyruvate metabolism",cardiac
38,ALS_A,BICD1,-0.2,51,"apoptosis, focal adhesion",skeletal
39,ALS_A,ANP32A,0.6,12,"Wnt signalling, Wnt signalling",smooth
40,ALS_A,KDSR,NA,52,"MAPK, MAPK",smooth
41,ALS_A,FBXO9,0.3,80,"propanoate metabolism, Wnt signalling",smooth
42,ALS_A,UBQLN2,1.1,28,"synthesis and degradation of ketone bodies, propanoate metabolism",cardiac
43,ALS_A,ZFX,NA,94,"cancer pathways, focal adhesion",skeletal
44,ALS_A,CPLX2,-0.3,69,"apoptosis, propanoate metabolism",skeletal
45,ALS_A,CLPX,0.3,3,"cancer pathways, fatty acid degradation",cardiac
46,ALS_A,SGCB,0.2,37,"propanoate metabolism, cancer pathways",cardiac
47,ALS_A,SEMA5A,-0.2,42,"cancer pathways, apoptosis",cardiac
48,ALS_A,PTPRB,NA,74,"focal adhesion, Wnt signalling",smooth
49,ALS_A,TMEM33,0.4,97,"pyruvate metabolism, MAPK",smooth
50,ALS_A,SMC1A,0.4,28,"MAPK, pyruvate metabolism",cardiac
51,AQM_A,NF1,0.6,75,"citrate cycle, propanoate metabolism",smooth
52,AQM_A,UEVLD,0.3,61,"focal adhesion, fatty acid degradation",skeletal
53,AQM_A,CDC37L1,0.5,21,"focal adhesion, focal adhesion",cardiac
54,AQM_A,HOXD10,-0.6,51,"synthesis and degradation of ketone bodies, propanoate metabolism",cardiac
55,AQM_A,NNT,-0.6,82,"focal adhesion, fatty acid degradation",cardiac
56,AQM_A,HUWE1,0.8,70,"citrate cycle, MAPK",cardiac
57,AQM_A,GJA5,-0.1,80,"MAPK, synthesis and degradation of ketone bodies",skeletal
58,AQM_A,SPCS3,0.5,13,"apoptosis, focal adhesion",smooth
59,AQM_A,DOT1L,-0.4,31,"apoptosis, Wnt signalling",smooth
60,AQM_A,ATP6V0E1,0.5,94,"apoptosis, propanoate metabolism",cardiac
61,AQM_A,XAF1,-0.2,76,"fatty acid degradation, pyruvate metabolism",skeletal
62,AQM_A,MAFG,NA,31,"propanoate metabolism, pyruvate metabolism",skeletal
63,AQM_A,AAK1,0.7,98,"focal adhesion, focal adhesion",skeletal
64,AQM_A,TM2D3,0.9,7,"apoptosis, propanoate metabolism",skeletal
65,AQM_A,SSR3,NA,8,"fatty acid degradation, citrate cycle",cardiac
66,AQM_A,ZNF281,-0.2,19,"Wnt signalling, synthesis and degradation of ketone bodies",skeletal
67,AQM_A,JAM2,-0.1,19,"propanoate metabolism, cancer pathways",cardiac
68,AQM_A,CDC23,0.6,64,"apoptosis, apoptosis",smooth
69,AQM_A,PLN,-2,87,"apoptosis, propanoate metabolism",skeletal
70,AQM_A,PGP,-0.4,74,"fatty acid degradation, synthesis and degradation of ketone bodies",smooth
71,AQM_A,HYI,-0.1,49,"MAPK, focal adhesion",skeletal
72,AQM_A,IMPACT,0.4,44,"citrate cycle, fatty acid degradation",skeletal
73,AQM_A,C2orf49,-0.1,37,"citrate cycle, citrate cycle",skeletal
74,AQM_A,HDAC11,-0.5,78,"fatty acid degradation, Wnt signalling",smooth
75,AQM_A,CCN4,-0.3,24,"cancer pathways, apoptosis",cardiac
76,AQM_A,MKLN1,0.7,75,"apoptosis, apoptosis",smooth
77,AQM_A,GPRC5B,0.1,48,"focal adhesion, cancer pathways",skeletal
78,AQM_A,RPS6KB1,0.7,7,"synthesis and degradation of ketone bodies, propanoate metabolism",smooth
79,AQM_A,PSMA3,0.6,66,"MAPK, fatty acid degradation",smooth
80,AQM_A,JARID2,-0.2,76,"propanoate metabolism, apoptosis",skeletal
81,AQM_A,ODF2,-0.1,98,"Wnt signalling, Wnt signalling",smooth
82,AQM_A,MON2,0.7,26,"cancer pathways, cancer pathways",cardiac
83,AQM_A,PDLIM2,-1.1,57,"pyruvate metabolism, synthesis and degradation of ketone bodies",skeletal
84,AQM_A,WAC,0.8,85,"propanoate metabolism, cancer pathways",smooth
85,AQM_A,FLCN,0.2,100,"fatty acid degradation, propanoate metabolism",cardiac
86,AQM_A,ATF6,0.2,31,"Wnt signalling, cancer pathways",cardiac
87,AQM_A,TRAFD1,-0.1,13,"fatty acid degradation, Wnt signalling",smooth
88,AQM_A,BICD1,-0.3,57,"focal adhesion, citrate cycle",skeletal
89,AQM_A,ANP32A,0.5,53,"cancer pathways, MAPK",skeletal
90,AQM_A,KDSR,0.3,71,"Wnt signalling, synthesis and degradation of ketone bodies",smooth
91,AQM_A,FBXO9,NA,8,"pyruvate metabolism, citrate cycle",smooth
92,AQM_A,UBQLN2,0.7,85,"propanoate metabolism, propanoate metabolism",skeletal
93,AQM_A,ZFX,-0.1,36,"propanoate metabolism, Wnt signalling",smooth
94,AQM_A,CPLX2,-0.3,11,"fatty acid degradation, pyruvate metabolism",skeletal
95,AQM_A,CLPX,0.3,73,"propanoate metabolism, cancer pathways",smooth
96,AQM_A,SGCB,0.3,60,"fatty acid degradation, Wnt signalling",smooth
97,AQM_A,SEMA5A,-0.4,20,"MAPK, synthesis and degradation of ketone bodies",smooth
98,AQM_A,PTPRB,-0.6,66,"cancer pathways, apoptosis",skeletal
99,AQM_A,TMEM33,0.6,21,"Wnt signalling, apoptosis",smooth
100,AQM_A,SMC1A,2.5,25,"fatty acid degradation, fatty acid degradation",cardiac
101,BMD_A,NF1,0.1,51,"cancer pathways, fatty acid degradation",cardiac
102,BMD_A,UEVLD,-0.1,63,"citrate cycle, MAPK",smooth
103,BMD_A,CDC37L1,NA,55,"MAPK, focal adhesion",cardiac
104,BMD_A,HOXD10,0.1,25,"pyruvate metabolism, cancer pathways",skeletal
105,BMD_A,NNT,-0.2,79,"citrate cycle, apoptosis",cardiac
106,BMD_A,HUWE1,0.1,37,"apoptosis, cancer pathways",cardiac
107,BMD_A,GJA5,NA,23,"focal adhesion, pyruvate metabolism",skeletal
108,BMD_A,SPCS3,0.6,40,"fatty acid degradation, MAPK",smooth
109,BMD_A,DOT1L,0.1,87,"pyruvate metabolism, synthesis and degradation of ketone bodies",smooth
110,BMD_A,ATP6V0E1,0.4,16,"propanoate metabolism, Wnt signalling",skeletal
111,BMD_A,XAF1,-0.1,8,"synthesis and degradation of ketone bodies, apoptosis",smooth
112,BMD_A,MAFG,-0.2,8,"focal adhesion, synthesis and degradation of ketone bodies",cardiac
113,BMD_A,AAK1,0.2,67,"apoptosis, citrate cycle",skeletal
114,BMD_A,TM2D3,0.1,45,"Wnt signalling, synthesis and degradation of ketone bodies",skeletal
115,BMD_A,SSR3,NA,21,"synthesis and degradation of ketone bodies, citrate cycle",skeletal
116,BMD_A,ZNF281,-0.2,29,"cancer pathways, MAPK",cardiac
117,BMD_A,JAM2,0.3,56,"apoptosis, apoptosis",skeletal
118,BMD_A,CDC23,0.1,15,"Wnt signalling, fatty acid degradation",cardiac
119,BMD_A,PLN,-0.7,86,"synthesis and degradation of ketone bodies, MAPK",smooth
120,BMD_A,PGP,0.2,78,"MAPK, apoptosis",skeletal
121,BMD_A,HYI,NA,34,"synthesis and degradation of ketone bodies, Wnt signalling",smooth
122,BMD_A,IMPACT,NA,24,"synthesis and degradation of ketone bodies, fatty acid degradation",smooth
123,BMD_A,C2orf49,-0.2,76,"Wnt signalling, citrate cycle",skeletal
124,BMD_A,HDAC11,NA,70,"apoptosis, MAPK",skeletal
125,BMD_A,CCN4,-0.3,87,"synthesis and degradation of ketone bodies, citrate cycle",smooth
126,BMD_A,MKLN1,NA,88,"cancer pathways, cancer pathways",cardiac
127,BMD_A,GPRC5B,NA,92,"pyruvate metabolism, propanoate metabolism",skeletal
128,BMD_A,RPS6KB1,-0.2,53,"fatty acid degradation, synthesis and degradation of ketone bodies",smooth
129,BMD_A,PSMA3,-0.2,5,"cancer pathways, apoptosis",smooth
130,BMD_A,JARID2,0.2,2,"Wnt signalling, citrate cycle",cardiac
131,BMD_A,ODF2,-0.1,15,"MAPK, citrate cycle",skeletal
132,BMD_A,MON2,-0.4,14,"Wnt signalling, focal adhesion",skeletal
133,BMD_A,PDLIM2,-0.5,36,"propanoate metabolism, propanoate metabolism",cardiac
134,BMD_A,WAC,-0.1,91,"propanoate metabolism, cancer pathways",skeletal
135,BMD_A,FLCN,NA,93,"apoptosis, Wnt signalling",skeletal
136,BMD_A,ATF6,NA,4,"citrate cycle, MAPK",skeletal
137,BMD_A,TRAFD1,0.2,10,"focal adhesion, cancer pathways",skeletal
138,BMD_A,BICD1,NA,72,"cancer pathways, Wnt signalling",cardiac
139,BMD_A,ANP32A,0.1,13,"synthesis and degradation of ketone bodies, citrate cycle",cardiac
140,BMD_A,KDSR,-0.4,36,"synthesis and degradation of ketone bodies, apoptosis",cardiac
141,BMD_A,FBXO9,NA,63,"synthesis and degradation of ketone bodies, focal adhesion",skeletal
142,BMD_A,UBQLN2,0.1,95,"pyruvate metabolism, synthesis and degradation of ketone bodies",skeletal
143,BMD_A,ZFX,-0.2,55,"synthesis and degradation of ketone bodies, Wnt signalling",cardiac
144,BMD_A,CPLX2,0.1,20,"synthesis and degradation of ketone bodies, apoptosis",smooth
145,BMD_A,CLPX,-0.1,95,"citrate cycle, focal adhesion",skeletal
146,BMD_A,SGCB,-0.1,52,"synthesis and degradation of ketone bodies, MAPK",cardiac
147,BMD_A,SEMA5A,-0.1,37,"synthesis and degradation of ketone bodies, apoptosis",cardiac
148,BMD_A,PTPRB,0.2,19,"synthesis and degradation of ketone bodies, focal adhesion",cardiac
149,BMD_A,TMEM33,-0.2,90,"fatty acid degradation, Wnt signalling",smooth
150,BMD_A,SMC1A,NA,82,"synthesis and degradation of ketone bodies, citrate cycle",smooth
151,DMD_A,NF1,0.3,17,"focal adhesion, MAPK",smooth
152,DMD_A,UEVLD,-0.1,68,"Wnt signalling, MAPK",smooth
153,DMD_A,CDC37L1,-0.3,63,"cancer pathways, pyruvate metabolism",smooth
154,DMD_A,HOXD10,-0.2,66,"Wnt signalling, fatty acid degradation",smooth
155,DMD_A,NNT,-0.4,39,"synthesis and degradation of ketone bodies, Wnt signalling",cardiac
156,DMD_A,HUWE1,0.1,64,"apoptosis, focal adhesion",skeletal
157,DMD_A,GJA5,-0.1,81,"MAPK, propanoate metabolism",cardiac
158,DMD_A,SPCS3,0.6,97,"cancer pathways, citrate cycle",skeletal
159,DMD_A,DOT1L,-0.2,42,"focal adhesion, propanoate metabolism",smooth
160,DMD_A,ATP6V0E1,0.4,5,"Wnt signalling, Wnt signalling",smooth
161,DMD_A,XAF1,0.1,81,"apoptosis, cancer pathways",cardiac
162,DMD_A,MAFG,-0.5,65,"citrate cycle, fatty acid degradation",skeletal
163,DMD_A,AAK1,0.1,76,"focal adhesion, pyruvate metabolism",cardiac
164,DMD_A,TM2D3,0.1,59,"fatty acid degradation, Wnt signalling",skeletal
165,DMD_A,SSR3,-0.1,58,"fatty acid degradation, MAPK",cardiac
166,DMD_A,ZNF281,-0.2,50,"cancer pathways, cancer pathways",cardiac
167,DMD_A,JAM2,1,32,"pyruvate metabolism, apoptosis",skeletal
168,DMD_A,CDC23,0.5,2,"citrate cycle, fatty acid degradation",cardiac
169,DMD_A,PLN,-0.6,0,"propanoate metabolism, cancer pathways",skeletal
170,DMD_A,PGP,-0.2,31,"focal adhesion, citrate cycle",smooth
171,DMD_A,HYI,-0.1,13,"MAPK, citrate cycle",skeletal
172,DMD_A,IMPACT,0.3,55,"propanoate metabolism, synthesis and degradation of ketone bodies",smooth
173,DMD_A,C2orf49,-0.2,41,"focal adhesion, synthesis and degradation of ketone bodies",skeletal
174,DMD_A,HDAC11,-0.3,91,"citrate cycle, Wnt signalling",smooth
175,DMD_A,CCN4,-0.4,9,"Wnt signalling, propanoate metabolism",skeletal
176,DMD_A,MKLN1,-0.1,51,"Wnt signalling, apoptosis",smooth
177,DMD_A,GPRC5B,NA,47,"fatty acid degradation, citrate cycle",skeletal
178,DMD_A,RPS6KB1,-0.1,15,"Wnt signalling, cancer pathways",skeletal
179,DMD_A,PSMA3,-0.1,72,"citrate cycle, citrate cycle",skeletal
180,DMD_A,JARID2,0.1,26,"fatty acid degradation, cancer pathways",cardiac
181,DMD_A,ODF2,-0.3,39,"citrate cycle, Wnt signalling",smooth
182,DMD_A,MON2,0.3,80,"citrate cycle, synthesis and degradation of ketone bodies",skeletal
183,DMD_A,PDLIM2,-0.8,2,"synthesis and degradation of ketone bodies, fatty acid degradation",smooth
184,DMD_A,WAC,0.5,67,"focal adhesion, cancer pathways",smooth
185,DMD_A,FLCN,0.1,63,"focal adhesion, pyruvate metabolism",smooth
186,DMD_A,ATF6,NA,3,"Wnt signalling, MAPK",skeletal
187,DMD_A,TRAFD1,0.2,78,"focal adhesion, fatty acid degradation",skeletal
188,DMD_A,BICD1,-0.1,61,"pyruvate metabolism, fatty acid degradation",smooth
189,DMD_A,ANP32A,0.3,32,"apoptosis, pyruvate metabolism",cardiac
190,DMD_A,KDSR,0.2,66,"fatty acid degradation, MAPK",smooth
191,DMD_A,FBXO9,0.3,77,"pyruvate metabolism, propanoate metabolism",cardiac
192,DMD_A,UBQLN2,0.1,39,"focal adhesion, citrate cycle",smooth
193,DMD_A,ZFX,-0.4,37,"MAPK, propanoate metabolism",smooth
194,DMD_A,CPLX2,-0.2,30,"apoptosis, propanoate metabolism",smooth
195,DMD_A,CLPX,-0.3,63,"Wnt signalling, cancer pathways",smooth
196,DMD_A,SGCB,-0.2,46,"cancer pathways, cancer pathways",skeletal
197,DMD_A,SEMA5A,-0.3,64,"propanoate metabolism, fatty acid degradation",skeletal
198,DMD_A,PTPRB,0.3,39,"apoptosis, citrate cycle",cardiac
199,DMD_A,TMEM33,0.1,73,"cancer pathways, cancer pathways",skeletal
200,DMD_A,SMC1A,0.5,52,"fatty acid degradation, propanoate metabolism",skeletal
201,EDMD.AD_A,NF1,0.7,18,"apoptosis, citrate cycle",skeletal
202,EDMD.AD_A,UEVLD,-0.2,81,"MAPK, Wnt signalling",cardiac
203,EDMD.AD_A,CDC37L1,0.6,3,"propanoate metabolism, synthesis and degradation of ketone bodies",smooth
204,EDMD.AD_A,HOXD10,-0.4,52,"Wnt signalling, focal adhesion",cardiac
205,EDMD.AD_A,NNT,-0.3,60,"fatty acid degradation, focal adhesion",smooth
206,EDMD.AD_A,HUWE1,0.4,32,"fatty acid degradation, citrate cycle",skeletal
207,EDMD.AD_A,GJA5,NA,80,"fatty acid degradation, cancer pathways",skeletal
208,EDMD.AD_A,SPCS3,0.5,74,"Wnt signalling, synthesis and degradation of ketone bodies",skeletal
209,EDMD.AD_A,DOT1L,-0.2,28,"fatty acid degradation, propanoate metabolism",cardiac
210,EDMD.AD_A,ATP6V0E1,0.5,52,"cancer pathways, apoptosis",skeletal
211,EDMD.AD_A,XAF1,-0.2,76,"focal adhesion, pyruvate metabolism",smooth
212,EDMD.AD_A,MAFG,-0.3,29,"fatty acid degradation, fatty acid degradation",cardiac
213,EDMD.AD_A,AAK1,0.2,1,"apoptosis, propanoate metabolism",skeletal
214,EDMD.AD_A,TM2D3,0.6,79,"apoptosis, synthesis and degradation of ketone bodies",smooth
215,EDMD.AD_A,SSR3,-0.4,55,"focal adhesion, synthesis and degradation of ketone bodies",smooth
216,EDMD.AD_A,ZNF281,-0.3,59,"cancer pathways, propanoate metabolism",cardiac
217,EDMD.AD_A,JAM2,0.5,27,"MAPK, cancer pathways",smooth
218,EDMD.AD_A,CDC23,0.6,91,"MAPK, pyruvate metabolism",smooth
219,EDMD.AD_A,PLN,-0.5,32,"propanoate metabolism, citrate cycle",cardiac
220,EDMD.AD_A,PGP,-0.2,99,"Wnt signalling, cancer pathways",cardiac
221,EDMD.AD_A,HYI,-0.1,42,"apoptosis, synthesis and degradation of ketone bodies",cardiac
222,EDMD.AD_A,IMPACT,0.3,22,"citrate cycle, citrate cycle",smooth
223,EDMD.AD_A,C2orf49,-0.1,98,"MAPK, synthesis and degradation of ketone bodies",cardiac
224,EDMD.AD_A,HDAC11,-0.3,22,"MAPK, focal adhesion",cardiac
225,EDMD.AD_A,CCN4,-0.4,41,"propanoate metabolism, synthesis and degradation of ketone bodies",cardiac
226,EDMD.AD_A,MKLN1,0.2,69,"MAPK, cancer pathways",skeletal
227,EDMD.AD_A,GPRC5B,0.2,34,"fatty acid degradation, fatty acid degradation",smooth
228,EDMD.AD_A,RPS6KB1,NA,97,"pyruvate metabolism, citrate cycle",skeletal
229,EDMD.AD_A,PSMA3,0.3,64,"Wnt signalling, MAPK",smooth
230,EDMD.AD_A,JARID2,0.1,57,"synthesis and degradation of ketone bodies, synthesis and degradation of ketone bodies",cardiac
231,EDMD.AD_A,ODF2,-0.2,79,"MAPK, focal adhesion",skeletal
232,EDMD.AD_A,MON2,0.4,55,"propanoate metabolism, Wnt signalling",cardiac
233,EDMD.AD_A,PDLIM2,-0.6,75,"fatty acid degradation, propanoate metabolism",smooth
234,EDMD.AD_A,WAC,1,53,"citrate cycle, synthesis and degradation of ketone bodies",smooth
235,EDMD.AD_A,FLCN,0.1,81,"pyruvate metabolism, pyruvate metabolism",cardiac
236,EDMD.AD_A,ATF6,NA,44,"pyruvate metabolism, synthesis and degradation of ketone bodies",cardiac
237,EDMD.AD_A,TRAFD1,NA,96,"Wnt signalling, focal adhesion",smooth
238,EDMD.AD_A,BICD1,-0.2,85,"Wnt signalling, Wnt signalling",cardiac
239,EDMD.AD_A,ANP32A,0.5,91,"cancer pathways, propanoate metabolism",smooth
240,EDMD.AD_A,KDSR,0.2,95,"synthesis and degradation of ketone bodies, propanoate metabolism",cardiac
241,EDMD.AD_A,FBXO9,-0.1,26,"citrate cycle, Wnt signalling",smooth
242,EDMD.AD_A,UBQLN2,0.7,77,"fatty acid degradation, propanoate metabolism",smooth
243,EDMD.AD_A,ZFX,-0.4,23,"focal adhesion, cancer pathways",skeletal
244,EDMD.AD_A,CPLX2,-0.3,98,"pyruvate metabolism, propanoate metabolism",smooth
245,EDMD.AD_A,CLPX,0.3,93,"citrate cycle, pyruvate metabolism",cardiac
246,EDMD.AD_A,SGCB,-0.3,37,"fatty acid degradation, fatty acid degradation",smooth
247,EDMD.AD_A,SEMA5A,-0.1,25,"pyruvate metabolism, focal adhesion",skeletal
248,EDMD.AD_A,PTPRB,-0.3,64,"Wnt signalling, citrate cycle",smooth
249,EDMD.AD_A,TMEM33,0.2,40,"Wnt signalling, citrate cycle",skeletal
250,EDMD.AD_A,SMC1A,0.9,65,"Wnt signalling, fatty acid degradation",smooth
251,EDMD.XR_A,NF1,0.2,62,"apoptosis, synthesis and degradation of ketone bodies",cardiac
252,EDMD.XR_A,UEVLD,NA,62,"focal adhesion, pyruvate metabolism",cardiac
253,EDMD.XR_A,CDC37L1,0.6,59,"propanoate metabolism, cancer pathways",smooth
254,EDMD.XR_A,HOXD10,NA,72,"pyruvate metabolism, synthesis and degradation of ketone bodies",cardiac
255,EDMD.XR_A,NNT,-0.1,59,"citrate cycle, apoptosis",cardiac
256,EDMD.XR_A,HUWE1,0.3,49,"Wnt signalling, citrate cycle",cardiac
257,EDMD.XR_A,GJA5,NA,88,"MAPK, cancer pathways",cardiac
258,EDMD.XR_A,SPCS3,0.4,49,"synthesis and degradation of ketone bodies, propanoate metabolism",smooth
259,EDMD.XR_A,DOT1L,NA,11,"MAPK, synthesis and degradation of ketone bodies",cardiac
260,EDMD.XR_A,ATP6V0E1,0.4,36,"propanoate metabolism, fatty acid degradation",skeletal
261,EDMD.XR_A,XAF1,NA,8,"synthesis and degradation of ketone bodies, pyruvate metabolism",skeletal
262,EDMD.XR_A,MAFG,-0.3,52,"Wnt signalling, focal adhesion",cardiac
263,EDMD.XR_A,AAK1,NA,32,"fatty acid degradation, citrate cycle",smooth
264,EDMD.XR_A,TM2D3,0.4,67,"focal adhesion, pyruvate metabolism",smooth
265,EDMD.XR_A,SSR3,NA,15,"MAPK, synthesis and degradation of ketone bodies",cardiac
266,EDMD.XR_A,ZNF281,NA,45,"focal adhesion, apoptosis",skeletal
267,EDMD.XR_A,JAM2,NA,59,"apoptosis, MAPK",skeletal
268,EDMD.XR_A,CDC23,0.3,53,"synthesis and degradation of ketone bodies, synthesis and degradation of ketone bodies",cardiac
269,EDMD.XR_A,PLN,-0.3,9,"cancer pathways, Wnt signalling",skeletal
270,EDMD.XR_A,PGP,-0.1,33,"synthesis and degradation of ketone bodies, apoptosis",cardiac
271,EDMD.XR_A,HYI,0.1,100,"fatty acid degradation, propanoate metabolism",skeletal
272,EDMD.XR_A,IMPACT,NA,22,"Wnt signalling, pyruvate metabolism",smooth
273,EDMD.XR_A,C2orf49,NA,17,"citrate cycle, focal adhesion",skeletal
274,EDMD.XR_A,HDAC11,NA,38,"focal adhesion, MAPK",smooth
275,EDMD.XR_A,CCN4,NA,44,"citrate cycle, fatty acid degradation",cardiac
276,EDMD.XR_A,MKLN1,NA,69,"Wnt signalling, cancer pathways",cardiac
277,EDMD.XR_A,GPRC5B,0.1,58,"MAPK, cancer pathways",skeletal
278,EDMD.XR_A,RPS6KB1,0.1,93,"citrate cycle, focal adhesion",skeletal
279,EDMD.XR_A,PSMA3,0.1,52,"pyruvate metabolism, cancer pathways",skeletal
280,EDMD.XR_A,JARID2,NA,35,"focal adhesion, pyruvate metabolism",smooth
281,EDMD.XR_A,ODF2,-0.2,68,"propanoate metabolism, Wnt signalling",cardiac
282,EDMD.XR_A,MON2,NA,5,"MAPK, MAPK",smooth
283,EDMD.XR_A,PDLIM2,-0.6,58,"pyruvate metabolism, fatty acid degradation",cardiac
284,EDMD.XR_A,WAC,0.5,57,"cancer pathways, apoptosis",smooth
285,EDMD.XR_A,FLCN,NA,5,"citrate cycle, Wnt signalling",cardiac
286,EDMD.XR_A,ATF6,NA,90,"propanoate metabolism, propanoate metabolism",cardiac
287,EDMD.XR_A,TRAFD1,NA,16,"pyruvate metabolism, citrate cycle",smooth
288,EDMD.XR_A,BICD1,NA,8,"fatty acid degradation, pyruvate metabolism",smooth
289,EDMD.XR_A,ANP32A,0.5,91,"cancer pathways, Wnt signalling",cardiac
290,EDMD.XR_A,KDSR,0.2,37,"cancer pathways, pyruvate metabolism",cardiac
291,EDMD.XR_A,FBXO9,0.2,92,"apoptosis, Wnt signalling",skeletal
292,EDMD.XR_A,UBQLN2,0.3,75,"synthesis and degradation of ketone bodies, propanoate metabolism",skeletal
293,EDMD.XR_A,ZFX,NA,22,"fatty acid degradation, Wnt signalling",cardiac
294,EDMD.XR_A,CPLX2,NA,68,"MAPK, apoptosis",skeletal
295,EDMD.XR_A,CLPX,NA,69,"pyruvate metabolism, MAPK",skeletal
296,EDMD.XR_A,SGCB,-0.2,60,"cancer pathways, Wnt signalling",cardiac
297,EDMD.XR_A,SEMA5A,NA,46,"Wnt signalling, Wnt signalling",cardiac
298,EDMD.XR_A,PTPRB,-0.4,56,"synthesis and degradation of ketone bodies, Wnt signalling",smooth
299,EDMD.XR_A,TMEM33,0.3,31,"apoptosis, MAPK",smooth
300,EDMD.XR_A,SMC1A,0.1,80,"citrate cycle, fatty acid degradation",smooth
301,FSHD_A,NF1,0.1,67,"Wnt signalling, synthesis and degradation of ketone bodies",skeletal
302,FSHD_A,UEVLD,0.1,77,"MAPK, Wnt signalling",cardiac
303,FSHD_A,CDC37L1,-0.1,89,"synthesis and degradation of ketone bodies, cancer pathways",skeletal
304,FSHD_A,HOXD10,-0.2,85,"focal adhesion, fatty acid degradation",cardiac
305,FSHD_A,NNT,NA,74,"synthesis and degradation of ketone bodies, fatty acid degradation",smooth
306,FSHD_A,HUWE1,0.3,37,"fatty acid degradation, synthesis and degradation of ketone bodies",cardiac
307,FSHD_A,GJA5,-0.1,13,"cancer pathways, synthesis and degradation of ketone bodies",cardiac
308,FSHD_A,SPCS3,0.4,57,"fatty acid degradation, fatty acid degradation",smooth
309,FSHD_A,DOT1L,NA,22,"focal adhesion, synthesis and degradation of ketone bodies",smooth
310,FSHD_A,ATP6V0E1,0.2,75,"pyruvate metabolism, propanoate metabolism",skeletal
311,FSHD_A,XAF1,0.1,78,"cancer pathways, synthesis and degradation of ketone bodies",cardiac
312,FSHD_A,MAFG,0.3,27,"citrate cycle, propanoate metabolism",skeletal
313,FSHD_A,AAK1,0.3,59,"focal adhesion, citrate cycle",cardiac
314,FSHD_A,TM2D3,0.6,46,"apoptosis, synthesis and degradation of ketone bodies",skeletal
315,FSHD_A,SSR3,-0.1,82,"Wnt signalling, synthesis and degradation of ketone bodies",cardiac
316,FSHD_A,ZNF281,0.3,79,"focal adhesion, pyruvate metabolism",smooth
317,FSHD_A,JAM2,0.2,48,"Wnt signalling, pyruvate metabolism",skeletal
318,FSHD_A,CDC23,0.3,56,"citrate cycle, citrate cycle",smooth
319,FSHD_A,PLN,-0.1,2,"cancer pathways, Wnt signalling",cardiac
320,FSHD_A,PGP,-0.1,98,"fatty acid degradation, synthesis and degradation of ketone bodies",cardiac
321,FSHD_A,HYI,-0.1,56,"fatty acid degradation, pyruvate metabolism",skeletal
322,FSHD_A,IMPACT,0.2,49,"apoptosis, cancer pathways",smooth
323,FSHD_A,C2orf49,-0.1,54,"synthesis and degradation of ketone bodies, focal adhesion",cardiac
324,FSHD_A,HDAC11,-0.2,56,"fatty acid degradation, Wnt signalling",skeletal
325,FSHD_A,CCN4,-0.2,61,"pyruvate metabolism, cancer pathways",cardiac
326,FSHD_A,MKLN1,NA,34,"focal adhesion, citrate cycle",cardiac
327,FSHD_A,GPRC5B,0.4,84,"pyruvate metabolism, focal adhesion",skeletal
328,FSHD_A,RPS6KB1,0.4,40,"citrate cycle, apoptosis",smooth
329,FSHD_A,PSMA3,0.3,68,"pyruvate metabolism, apoptosis",skeletal
330,FSHD_A,JARID2,-0.1,77,"fatty acid degradation, pyruvate metabolism",smooth
331,FSHD_A,ODF2,-0.1,13,"citrate cycle, MAPK",smooth
332,FSHD_A,MON2,0.2,63,"apoptosis, Wnt signalling",skeletal
333,FSHD_A,PDLIM2,-0.1,31,"pyruvate metabolism, Wnt signalling",smooth
334,FSHD_A,WAC,0.2,18,"cancer pathways, MAPK",cardiac
335,FSHD_A,FLCN,0.1,67,"focal adhesion, citrate cycle",skeletal
336,FSHD_A,ATF6,NA,87,"apoptosis, apoptosis",smooth
337,FSHD_A,TRAFD1,NA,21,"fatty acid degradation, cancer pathways",smooth
338,FSHD_A,BICD1,-0.2,2,"MAPK, Wnt signalling",skeletal
339,FSHD_A,ANP32A,0.3,47,"fatty acid degradation, MAPK",cardiac
340,FSHD_A,KDSR,0.4,85,"propanoate metabolism, MAPK",cardiac
341,FSHD_A,FBXO9,0.1,73,"MAPK, propanoate metabolism",skeletal
342,FSHD_A,UBQLN2,0.9,68,"citrate cycle, apoptosis",skeletal
343,FSHD_A,ZFX,-0.2,48,"propanoate metabolism, fatty acid degradation",skeletal
344,FSHD_A,CPLX2,-0.3,10,"propanoate metabolism, Wnt signalling",skeletal
345,FSHD_A,CLPX,0.3,71,"Wnt signalling, apoptosis",smooth
346,FSHD_A,SGCB,0.3,35,"propanoate metabolism, citrate cycle",smooth
347,FSHD_A,SEMA5A,-0.3,4,"MAPK, MAPK",cardiac
348,FSHD_A,PTPRB,0.1,90,"pyruvate metabolism, focal adhesion",skeletal
349,FSHD_A,TMEM33,0.3,74,"focal adhesion, propanoate metabolism",smooth
350,FSHD_A,SMC1A,0.7,48,"pyruvate metabolism, focal adhesion",skeletal
351,HSP_A,NF1,-0.6,9,"synthesis and degradation of ketone bodies, focal adhesion",cardiac
352,HSP_A,UEVLD,-0.3,5,"Wnt signalling, cancer pathways",skeletal
353,HSP_A,CDC37L1,-0.9,55,"synthesis and degradation of ketone bodies, MAPK",smooth
354,HSP_A,HOXD10,0.2,85,"cancer pathways, pyruvate metabolism",skeletal
355,HSP_A,NNT,-1.8,54,"cancer pathways, citrate cycle",smooth
356,HSP_A,HUWE1,0.1,3,"cancer pathways, fatty acid degradation",smooth
357,HSP_A,GJA5,0.4,47,"apoptosis, focal adhesion",skeletal
358,HSP_A,SPCS3,-0.5,82,"pyruvate metabolism, citrate cycle",smooth
359,HSP_A,DOT1L,0.2,70,"fatty acid degradation, MAPK",smooth
360,HSP_A,ATP6V0E1,-0.2,82,"citrate cycle, citrate cycle",cardiac
361,HSP_A,XAF1,-0.1,69,"propanoate metabolism, citrate cycle",skeletal
362,HSP_A,MAFG,0.3,13,"propanoate metabolism, pyruvate metabolism",skeletal
363,HSP_A,AAK1,-0.1,39,"citrate cycle, Wnt signalling",cardiac
364,HSP_A,TM2D3,-0.3,62,"focal adhesion, focal adhesion",smooth
365,HSP_A,SSR3,-0.4,18,"focal adhesion, apoptosis",smooth
366,HSP_A,ZNF281,-0.3,47,"synthesis and degradation of ketone bodies, Wnt signalling",skeletal
367,HSP_A,JAM2,NA,93,"citrate cycle, pyruvate metabolism",smooth
368,HSP_A,CDC23,NA,76,"citrate cycle, synthesis and degradation of ketone bodies",skeletal
369,HSP_A,PLN,-0.8,5,"Wnt signalling, citrate cycle",cardiac
370,HSP_A,PGP,0.3,57,"pyruvate metabolism, apoptosis",skeletal
371,HSP_A,HYI,0.5,42,"propanoate metabolism, citrate cycle",smooth
372,HSP_A,IMPACT,NA,12,"pyruvate metabolism, propanoate metabolism",skeletal
373,HSP_A,C2orf49,-0.3,36,"MAPK, cancer pathways",smooth
374,HSP_A,HDAC11,NA,14,"cancer pathways, cancer pathways",cardiac
375,HSP_A,CCN4,NA,4,"Wnt signalling, MAPK",smooth
376,HSP_A,MKLN1,NA,46,"propanoate metabolism, apoptosis",cardiac
377,HSP_A,GPRC5B,0.3,74,"MAPK, propanoate metabolism",cardiac
378,HSP_A,RPS6KB1,-0.3,94,"apoptosis, focal adhesion",skeletal
379,HSP_A,PSMA3,-1,3,"Wnt signalling, propanoate metabolism",cardiac
380,HSP_A,JARID2,NA,10,"citrate cycle, apoptosis",skeletal
381,HSP_A,ODF2,0.3,79,"Wnt signalling, MAPK",cardiac
382,HSP_A,MON2,-0.3,37,"fatty acid degradation, Wnt signalling",cardiac
383,HSP_A,PDLIM2,0.6,76,"pyruvate metabolism, fatty acid degradation",skeletal
384,HSP_A,WAC,-0.4,82,"propanoate metabolism, pyruvate metabolism",cardiac
385,HSP_A,FLCN,NA,83,"fatty acid degradation, propanoate metabolism",smooth
386,HSP_A,ATF6,NA,57,"fatty acid degradation, propanoate metabolism",smooth
387,HSP_A,TRAFD1,NA,92,"synthesis and degradation of ketone bodies, focal adhesion",cardiac
388,HSP_A,BICD1,NA,60,"apoptosis, pyruvate metabolism",smooth
389,HSP_A,ANP32A,-0.3,25,"pyruvate metabolism, Wnt signalling",smooth
390,HSP_A,KDSR,-0.4,62,"synthesis and degradation of ketone bodies, focal adhesion",skeletal
391,HSP_A,FBXO9,-0.5,91,"focal adhesion, propanoate metabolism",cardiac
392,HSP_A,UBQLN2,-0.6,56,"citrate cycle, MAPK",cardiac
393,HSP_A,ZFX,-0.3,6,"apoptosis, citrate cycle",smooth
394,HSP_A,CPLX2,0.2,22,"apoptosis, synthesis and degradation of ketone bodies",skeletal
395,HSP_A,CLPX,-0.4,42,"apoptosis, fatty acid degradation",skeletal
396,HSP_A,SGCB,-0.1,51,"fatty acid degradation, apoptosis",skeletal
397,HSP_A,SEMA5A,NA,54,"MAPK, citrate cycle",skeletal
398,HSP_A,PTPRB,-0.5,60,"synthesis and degradation of ketone bodies, citrate cycle",smooth
399,HSP_A,TMEM33,-0.3,32,"propanoate metabolism, cancer pathways",skeletal
400,HSP_A,SMC1A,-0.4,23,"pyruvate metabolism, pyruvate metabolism",smooth
401,JDM_A,NF1,0.3,97,"citrate cycle, fatty acid degradation",skeletal
402,JDM_A,UEVLD,0.2,13,"propanoate metabolism, MAPK",skeletal
403,JDM_A,CDC37L1,0.6,17,"propanoate metabolism, Wnt signalling",smooth
404,JDM_A,HOXD10,-0.3,60,"pyruvate metabolism, fatty acid degradation",cardiac
405,JDM_A,NNT,-1,97,"Wnt signalling, pyruvate metabolism",skeletal
406,JDM_A,HUWE1,0.2,25,"fatty acid degradation, focal adhesion",cardiac
407,JDM_A,GJA5,-0.2,98,"pyruvate metabolism, synthesis and degradation of ketone bodies",cardiac
408,JDM_A,SPCS3,0.7,64,"Wnt signalling, Wnt signalling",skeletal
409,JDM_A,DOT1L,-0.4,80,"Wnt signalling, fatty acid degradation",smooth
410,JDM_A,ATP6V0E1,0.5,24,"citrate cycle, propanoate metabolism",cardiac
411,JDM_A,XAF1,3.1,65,"propanoate metabolism, propanoate metabolism",cardiac
412,JDM_A,MAFG,0.2,12,"focal adhesion, synthesis and degradation of ketone bodies",cardiac
413,JDM_A,AAK1,0.6,14,"MAPK, cancer pathways",skeletal
414,JDM_A,TM2D3,0.8,51,"cancer pathways, MAPK",skeletal
415,JDM_A,SSR3,-0.1,84,"Wnt signalling, fatty acid degradation",skeletal
416,JDM_A,ZNF281,0.3,79,"fatty acid degradation, propanoate metabolism",smooth
417,JDM_A,JAM2,0.4,11,"synthesis and degradation of ketone bodies, fatty acid degradation",cardiac
418,JDM_A,CDC23,1,47,"cancer pathways, propanoate metabolism",cardiac
419,JDM_A,PLN,-0.5,34,"MAPK, propanoate metabolism",skeletal
420,JDM_A,PGP,-0.3,70,"MAPK, apoptosis",smooth
421,JDM_A,HYI,-0.3,29,"cancer pathways, pyruvate metabolism",cardiac
422,JDM_A,IMPACT,0.3,51,"propanoate metabolism, synthesis and degradation of ketone bodies",skeletal
423,JDM_A,C2orf49,NA,5,"citrate cycle, apoptosis",smooth
424,JDM_A,HDAC11,-0.4,16,"cancer pathways, MAPK",skeletal
425,JDM_A,CCN4,-0.5,52,"Wnt signalling, cancer pathways",cardiac
426,JDM_A,MKLN1,0.3,11,"MAPK, apoptosis",smooth
427,JDM_A,GPRC5B,NA,5,"pyruvate metabolism, citrate cycle",cardiac
428,JDM_A,RPS6KB1,0.6,29,"synthesis and degradation of ketone bodies, citrate cycle",skeletal
429,JDM_A,PSMA3,0.6,20,"focal adhesion, pyruvate metabolism",cardiac
430,JDM_A,JARID2,0.1,92,"synthesis and degradation of ketone bodies, pyruvate metabolism",smooth
431,JDM_A,ODF2,-0.4,87,"MAPK, fatty acid degradation",cardiac
432,JDM_A,MON2,0.6,45,"propanoate metabolism, focal adhesion",skeletal
433,JDM_A,PDLIM2,-0.4,39,"Wnt signalling, Wnt signalling",cardiac
434,JDM_A,WAC,0.9,26,"MAPK, apoptosis",skeletal
435,JDM_A,FLCN,0.4,63,"pyruvate metabolism, pyruvate metabolism",cardiac
436,JDM_A,ATF6,0.1,5,"pyruvate metabolism, fatty acid degradation",skeletal
437,JDM_A,TRAFD1,0.6,98,"synthesis and degradation of ketone bodies, Wnt signalling",smooth
438,JDM_A,BICD1,-0.3,59,"fatty acid degradation, citrate cycle",smooth
439,JDM_A,ANP32A,0.5,14,"synthesis and degradation of ketone bodies, apoptosis",cardiac
440,JDM_A,KDSR,0.6,9,"pyruvate metabolism, focal adhesion",smooth
441,JDM_A,FBXO9,0.3,91,"cancer pathways, Wnt signalling",smooth
442,JDM_A,UBQLN2,0.9,12,"focal adhesion, pyruvate metabolism",smooth
443,JDM_A,ZFX,-0.2,51,"synthesis and degradation of ketone bodies, apoptosis",cardiac
444,JDM_A,CPLX2,-0.4,99,"MAPK, cancer pathways",skeletal
445,JDM_A,CLPX,0.3,86,"propanoate metabolism, focal adhesion",smooth
446,JDM_A,SGCB,0.2,65,"propanoate metabolism, apoptosis",cardiac
447,JDM_A,SEMA5A,-0.4,81,"cancer pathways, propanoate metabolism",smooth
448,JDM_A,PTPRB,0.1,27,"propanoate metabolism, citrate cycle",skeletal
449,JDM_A,TMEM33,0.5,30,"propanoate metabolism, Wnt signalling",cardiac
450,JDM_A,SMC1A,1.6,92,"citrate cycle, Wnt signalling",cardiac
451,LGMD2A_A,NF1,0.1,65,"propanoate metabolism, pyruvate metabolism",cardiac
452,LGMD2A_A,UEVLD,-0.2,48,"MAPK, MAPK",smooth
453,LGMD2A_A,CDC37L1,-0.4,6,"citrate cycle, fatty acid degradation",cardiac
454,LGMD2A_A,HOXD10,-0.1,6,"pyruvate metabolism, synthesis and degradation of ketone bodies",smooth
455,LGMD2A_A,NNT,-0.8,8,"apoptosis, cancer pathways",smooth
456,LGMD2A_A,HUWE1,0.1,71,"MAPK, cancer pathways",smooth
457,LGMD2A_A,GJA5,NA,37,"apoptosis, citrate cycle",cardiac
458,LGMD2A_A,SPCS3,0.2,95,"Wnt signalling, propanoate metabolism",skeletal
459,LGMD2A_A,DOT1L,-0.1,14,"focal adhesion, fatty acid degradation",skeletal
460,LGMD2A_A,ATP6V0E1,0.2,79,"synthesis and degradation of ketone bodies, MAPK",smooth
461,LGMD2A_A,XAF1,NA,82,"synthesis and degradation of ketone bodies, citrate cycle",cardiac
462,LGMD2A_A,MAFG,-0.1,91,"fatty acid degradation, focal adhesion",smooth
463,LGMD2A_A,AAK1,NA,84,"fatty acid degradation, propanoate metabolism",skeletal
464,LGMD2A_A,TM2D3,-0.1,20,"apoptosis, pyruvate metabolism",skeletal
465,LGMD2A_A,SSR3,-0.3,44,"citrate cycle, focal adhesion",smooth
466,LGMD2A_A,ZNF281,-0.2,95,"cancer pathways, focal adhesion",cardiac
467,LGMD2A_A,JAM2,0.4,93,"MAPK, cancer pathways",skeletal
468,LGMD2A_A,CDC23,0.1,29,"propanoate metabolism, focal adhesion",skeletal
469,LGMD2A_A,PLN,-0.9,16,"citrate cycle, fatty acid degradation",skeletal
470,LGMD2A_A,PGP,0.1,10,"propanoate metabolism, propanoate metabolism",skeletal
471,LGMD2A_A,HYI,0.2,76,"propanoate metabolism, pyruvate metabolism",skeletal
472,LGMD2A_A,IMPACT,NA,37,"pyruvate metabolism, pyruvate metabolism",smooth
473,LGMD2A_A,C2orf49,-0.3,54,"propanoate metabolism, synthesis and degradation of ketone bodies",cardiac
474,LGMD2A_A,HDAC11,NA,100,"cancer pathways, synthesis and degradation of ketone bodies",cardiac
475,LGMD2A_A,CCN4,-0.2,80,"pyruvate metabolism, apoptosis",skeletal
476,LGMD2A_A,MKLN1,-0.2,7,"fatty acid degradation, apoptosis",smooth
477,LGMD2A_A,GPRC5B,NA,28,"citrate cycle, fatty acid degradation",smooth
478,LGMD2A_A,RPS6KB1,-0.2,28,"cancer pathways, focal adhesion",skeletal
479,LGMD2A_A,PSMA3,-0.2,92,"focal adhesion, synthesis and degradation of ketone bodies",smooth
480,LGMD2A_A,JARID2,0.1,64,"synthesis and degradation of ketone bodies, synthesis and degradation of ketone bodies",cardiac
481,LGMD2A_A,ODF2,NA,47,"fatty acid degradation, propanoate metabolism",cardiac
482,LGMD2A_A,MON2,-0.2,95,"MAPK, apoptosis",smooth
483,LGMD2A_A,PDLIM2,-0.7,56,"cancer pathways, fatty acid degradation",cardiac
484,LGMD2A_A,WAC,0.1,82,"cancer pathways, synthesis and degradation of ketone bodies",smooth
485,LGMD2A_A,FLCN,-0.1,39,"fatty acid degradation, propanoate metabolism",cardiac
486,LGMD2A_A,ATF6,NA,0,"cancer pathways, Wnt signalling",cardiac
487,LGMD2A_A,TRAFD1,NA,74,"citrate cycle, apoptosis",cardiac
488,LGMD2A_A,BICD1,NA,48,"Wnt signalling, Wnt signalling",cardiac
489,LGMD2A_A,ANP32A,0.1,30,"focal adhesion, cancer pathways",skeletal
490,LGMD2A_A,KDSR,-0.1,6,"MAPK, synthesis and degradation of ketone bodies",skeletal
491,LGMD2A_A,FBXO9,NA,89,"pyruvate metabolism, citrate cycle",cardiac
492,LGMD2A_A,UBQLN2,-0.3,85,"apoptosis, apoptosis",cardiac
493,LGMD2A_A,ZFX,-0.3,23,"apoptosis, Wnt signalling",smooth
494,LGMD2A_A,CPLX2,NA,74,"MAPK, Wnt signalling",skeletal
495,LGMD2A_A,CLPX,-0.3,78,"citrate cycle, fatty acid degradation",cardiac
496,LGMD2A_A,SGCB,-0.1,89,"pyruvate metabolism, propanoate metabolism",cardiac
497,LGMD2A_A,SEMA5A,NA,91,"apoptosis, fatty acid degradation",cardiac
498,LGMD2A_A,PTPRB,-0.3,49,"pyruvate metabolism, focal adhesion",cardiac
499,LGMD2A_A,TMEM33,-0.2,88,"propanoate metabolism, Wnt signalling",smooth
500,LGMD2A_A,SMC1A,0.1,17,"apoptosis, propanoate metabolism",cardiac
501,LGMD2B_A,NF1,0.1,11,"MAPK, propanoate metabolism",skeletal
502,LGMD2B_A,UEVLD,-0.2,39,"citrate cycle, propanoate metabolism",skeletal
503,LGMD2B_A,CDC37L1,-0.2,89,"Wnt signalling, pyruvate metabolism",skeletal
504,LGMD2B_A,HOXD10,0.1,6,"MAPK, pyruvate metabolism",skeletal
505,LGMD2B_A,NNT,-0.8,72,"focal adhesion, MAPK",skeletal
506,LGMD2B_A,HUWE1,0.1,87,"pyruvate metabolism, synthesis and degradation of ketone bodies",cardiac
507,LGMD2B_A,GJA5,NA,72,"citrate cycle, focal adhesion",smooth
508,LGMD2B_A,SPCS3,0.3,56,"citrate cycle, fatty acid degradation",skeletal
509,LGMD2B_A,DOT1L,NA,25,"apoptosis, focal adhesion",cardiac
510,LGMD2B_A,ATP6V0E1,0.1,54,"Wnt signalling, apoptosis",cardiac
511,LGMD2B_A,XAF1,NA,9,"focal adhesion, fatty acid degradation",smooth
512,LGMD2B_A,MAFG,-0.2,9,"apoptosis, propanoate metabolism",cardiac
513,LGMD2B_A,AAK1,0.2,18,"MAPK, synthesis and degradation of ketone bodies",smooth
514,LGMD2B_A,TM2D3,-0.1,38,"Wnt signalling, citrate cycle",cardiac
515,LGMD2B_A,SSR3,-0.3,49,"apoptosis, Wnt signalling",smooth
516,LGMD2B_A,ZNF281,-0.4,79,"MAPK, propanoate metabolism",skeletal
517,LGMD2B_A,JAM2,0.1,42,"apoptosis, focal adhesion",cardiac
518,LGMD2B_A,CDC23,0.1,20,"fatty acid degradation, apoptosis",skeletal
519,LGMD2B_A,PLN,-0.9,33,"propanoate metabolism, apoptosis",cardiac
520,LGMD2B_A,PGP,0.1,92,"Wnt signalling, fatty acid degradation",smooth
521,LGMD2B_A,HYI,0.1,39,"synthesis and degradation of ketone bodies, apoptosis",smooth
522,LGMD2B_A,IMPACT,-0.1,54,"synthesis and degradation of ketone bodies, citrate cycle",cardiac
523,LGMD2B_A,C2orf49,-0.2,91,"apoptosis, propanoate metabolism",skeletal
524,LGMD2B_A,HDAC11,NA,64,"fatty acid degradation, focal adhesion",cardiac
525,LGMD2B_A,CCN4,-0.2,28,"focal adhesion, citrate cycle",smooth
526,LGMD2B_A,MKLN1,-0.1,83,"citrate cycle, citrate cycle",skeletal
527,LGMD2B_A,GPRC5B,-0.3,44,"cancer pathways, fatty acid degradation",smooth
528,LGMD2B_A,RPS6KB1,-0.2,21,"fatty acid degradation, synthesis and degradation of ketone bodies",skeletal
529,LGMD2B_A,PSMA3,-0.4,39,"focal adhesion, pyruvate metabolism",skeletal
530,LGMD2B_A,JARID2,0.1,49,"focal adhesion, citrate cycle",cardiac
531,LGMD2B_A,ODF2,-0.1,55,"cancer pathways, apoptosis",smooth
532,LGMD2B_A,MON2,-0.1,0,"propanoate metabolism, Wnt signalling",smooth
533,LGMD2B_A,PDLIM2,-0.8,60,"apoptosis, MAPK",smooth
534,LGMD2B_A,WAC,-0.2,88,"MAPK, focal adhesion",skeletal
535,LGMD2B_A,FLCN,NA,35,"synthesis and degradation of ketone bodies, cancer pathways",smooth
536,LGMD2B_A,ATF6,-0.1,78,"cancer pathways, Wnt signalling",smooth
537,LGMD2B_A,TRAFD1,0.2,75,"Wnt signalling, focal adhesion",smooth
538,LGMD2B_A,BICD1,NA,83,"apoptosis, focal adhesion",smooth
539,LGMD2B_A,ANP32A,-0.2,76,"focal adhesion, synthesis and degradation of ketone bodies",skeletal
540,LGMD2B_A,KDSR,-0.4,73,"propanoate metabolism, citrate cycle",smooth
541,LGMD2B_A,FBXO9,NA,5,"fatty acid degradation, focal adhesion",smooth
542,LGMD2B_A,UBQLN2,-0.2,62,"focal adhesion, citrate cycle",cardiac
543,LGMD2B_A,ZFX,-0.4,83,"focal adhesion, synthesis and degradation of ketone bodies",skeletal
544,LGMD2B_A,CPLX2,0.2,35,"synthesis and degradation of ketone bodies, apoptosis",cardiac
545,LGMD2B_A,CLPX,-0.3,62,"MAPK, synthesis and degradation of ketone bodies",skeletal
546,LGMD2B_A,SGCB,-0.1,85,"propanoate metabolism, citrate cycle",cardiac
547,LGMD2B_A,SEMA5A,-0.1,16,"MAPK, apoptosis",cardiac
548,LGMD2B_A,PTPRB,-0.2,32,"cancer pathways, MAPK",cardiac
549,LGMD2B_A,TMEM33,-0.3,82,"apoptosis, MAPK",smooth
550,LGMD2B_A,SMC1A,NA,6,"synthesis and degradation of ketone bodies, citrate cycle",skeletal
551,LGMD2I_A,NF1,0.1,22,"pyruvate metabolism, synthesis and degradation of ketone bodies",smooth
552,LGMD2I_A,UEVLD,-0.2,18,"apoptosis, citrate cycle",cardiac
553,LGMD2I_A,CDC37L1,0.2,13,"pyruvate metabolism, citrate cycle",skeletal
554,LGMD2I_A,HOXD10,0.1,73,"MAPK, fatty acid degradation",cardiac
555,LGMD2I_A,NNT,-0.3,45,"apoptosis, pyruvate metabolism",smooth
556,LGMD2I_A,HUWE1,0.1,72,"MAPK, pyruvate metabolism",smooth
557,LGMD2I_A,GJA5,NA,18,"focal adhesion, apoptosis",smooth
558,LGMD2I_A,SPCS3,0.3,5,"Wnt signalling, propanoate metabolism",skeletal
559,LGMD2I_A,DOT1L,0.2,66,"MAPK, focal adhesion",skeletal
560,LGMD2I_A,ATP6V0E1,0.2,17,"fatty acid degradation, fatty acid degradation",skeletal
561,LGMD2I_A,XAF1,0.1,96,"synthesis and degradation of ketone bodies, propanoate metabolism",smooth
562,LGMD2I_A,MAFG,-0.3,89,"focal adhesion, Wnt signalling",skeletal
563,LGMD2I_A,AAK1,0.1,53,"pyruvate metabolism, synthesis and degradation of ketone bodies",skeletal
564,LGMD2I_A,TM2D3,NA,28,"citrate cycle, focal adhesion",skeletal
565,LGMD2I_A,SSR3,-0.1,57,"pyruvate metabolism, apoptosis",smooth
566,LGMD2I_A,ZNF281,-0.2,83,"focal adhesion, focal adhesion",cardiac
567,LGMD2I_A,JAM2,0.1,10,"fatty acid degradation, synthesis and degradation of ketone bodies",skeletal
568,LGMD2I_A,CDC23,0.1,98,"Wnt signalling, focal adhesion",cardiac
569,LGMD2I_A,PLN,-0.1,89,"fatty acid degradation, apoptosis",cardiac
570,LGMD2I_A,PGP,0.2,88,"cancer pathways, synthesis and degradation of ketone bodies",skeletal
571,LGMD2I_A,HYI,0.2,85,"citrate cycle, citrate cycle",smooth
572,LGMD2I_A,IMPACT,-0.1,14,"fatty acid degradation, synthesis and degradation of ketone bodies",skeletal
573,LGMD2I_A,C2orf49,-0.3,3,"apoptosis, apoptosis",skeletal
574,LGMD2I_A,HDAC11,NA,89,"focal adhesion, fatty acid degradation",skeletal
575,LGMD2I_A,CCN4,-0.2,100,"propanoate metabolism, pyruvate metabolism",skeletal
576,LGMD2I_A,MKLN1,-0.2,87,"apoptosis, cancer pathways",cardiac
577,LGMD2I_A,GPRC5B,NA,30,"MAPK, fatty acid degradation",smooth
578,LGMD2I_A,RPS6KB1,-0.2,15,"pyruvate metabolism, Wnt signalling",skeletal
579,LGMD2I_A,PSMA3,0.2,78,"cancer pathways, focal adhesion",cardiac
580,LGMD2I_A,JARID2,-0.1,0,"Wnt signalling, cancer pathways",cardiac
581,LGMD2I_A,ODF2,-0.1,84,"Wnt signalling, MAPK",cardiac
582,LGMD2I_A,MON2,-0.3,91,"MAPK, MAPK",skeletal
583,LGMD2I_A,PDLIM2,-0.4,43,"focal adhesion, fatty acid degradation",smooth
584,LGMD2I_A,WAC,-0.1,8,"apoptosis, MAPK",smooth
585,LGMD2I_A,FLCN,NA,69,"pyruvate metabolism, pyruvate metabolism",cardiac
586,LGMD2I_A,ATF6,NA,93,"propanoate metabolism, focal adhesion",cardiac
587,LGMD2I_A,TRAFD1,0.3,15,"citrate cycle, synthesis and degradation of ketone bodies",skeletal
588,LGMD2I_A,BICD1,0.1,7,"MAPK, cancer pathways",skeletal
589,LGMD2I_A,ANP32A,NA,76,"synthesis and degradation of ketone bodies, focal adhesion",skeletal
590,LGMD2I_A,KDSR,-0.4,70,"pyruvate metabolism, propanoate metabolism",smooth
591,LGMD2I_A,FBXO9,NA,95,"Wnt signalling, cancer pathways",cardiac
592,LGMD2I_A,UBQLN2,-0.2,37,"propanoate metabolism, propanoate metabolism",skeletal
593,LGMD2I_A,ZFX,-0.3,67,"focal adhesion, fatty acid degradation",cardiac
594,LGMD2I_A,CPLX2,0.1,17,"focal adhesion, citrate cycle",skeletal
595,LGMD2I_A,CLPX,-0.1,49,"apoptosis, propanoate metabolism",cardiac
596,LGMD2I_A,SGCB,-0.2,55,"fatty acid degradation, apoptosis",skeletal
597,LGMD2I_A,SEMA5A,NA,41,"MAPK, cancer pathways",cardiac
598,LGMD2I_A,PTPRB,0.1,92,"propanoate metabolism, pyruvate metabolism",smooth
599,LGMD2I_A,TMEM33,-0.3,15,"fatty acid degradation, Wnt signalling",cardiac
600,LGMD2I_A,SMC1A,0.1,44,"synthesis and degradation of ketone bodies, focal adhesion",smooth
601,ALS_B,NF1,0.1,18,"apoptosis, fatty acid degradation",smooth
602,ALS_B,UEVLD,0.1,22,"focal adhesion, cancer pathways",cardiac
603,ALS_B,CDC37L1,0.5,91,"citrate cycle, focal adhesion",skeletal
604,ALS_B,HOXD10,-0.1,28,"fatty acid degradation, propanoate metabolism",skeletal
605,ALS_B,NNT,NA,41,"citrate cycle, citrate cycle",smooth
606,ALS_B,HUWE1,0.1,81,"Wnt signalling, cancer pathways",smooth
607,ALS_B,GJA5,-0.3,39,"focal adhesion, focal adhesion",skeletal
608,ALS_B,SPCS3,-0.1,96,"synthesis and degradation of ketone bodies, focal adhesion",skeletal
609,ALS_B,DOT1L,0.2,39,"synthesis and degradation of ketone bodies, citrate cycle",smooth
610,ALS_B,ATP6V0E1,0.4,73,"citrate cycle, pyruvate metabolism",skeletal
611,ALS_B,XAF1,0.1,95,"fatty acid degradation, citrate cycle",smooth
612,ALS_B,MAFG,-0.3,24,"cancer pathways, fatty acid degradation",smooth
613,ALS_B,AAK1,0.4,13,"focal adhesion, pyruvate metabolism",smooth
614,ALS_B,TM2D3,0.3,76,"cancer pathways, propanoate metabolism",cardiac
615,ALS_B,SSR3,0.3,57,"apoptosis, focal adhesion",cardiac
616,ALS_B,ZNF281,0.4,82,"apoptosis, synthesis and degradation of ketone bodies",smooth
617,ALS_B,JAM2,0.2,94,"synthesis and degradation of ketone bodies, Wnt signalling",smooth
618,ALS_B,CDC23,0.1,0,"citrate cycle, Wnt signalling",skeletal
619,ALS_B,PLN,-0.5,54,"MAPK, MAPK",cardiac
620,ALS_B,PGP,-0.1,56,"propanoate metabolism, citrate cycle",smooth
621,ALS_B,HYI,-0.1,45,"propanoate metabolism, pyruvate metabolism",cardiac
622,ALS_B,IMPACT,0.2,32,"MAPK, Wnt signalling",cardiac
623,ALS_B,C2orf49,0.3,15,"Wnt signalling, cancer pathways",cardiac
624,ALS_B,HDAC11,-0.6,46,"Wnt signalling, apoptosis",skeletal
625,ALS_B,CCN4,-0.2,51,"apoptosis, pyruvate metabolism",cardiac
626,ALS_B,MKLN1,0.6,80,"synthesis and degradation of ketone bodies, pyruvate metabolism",smooth
627,ALS_B,GPRC5B,0.3,92,"fatty acid degradation, Wnt signalling",smooth
628,ALS_B,RPS6KB1,0.6,42,"synthesis and degradation of ketone bodies, cancer pathways",cardiac
629,ALS_B,PSMA3,-0.1,52,"propanoate metabolism, focal adhesion",skeletal
630,ALS_B,JARID2,-0.3,93,"fatty acid degradation, cancer pathways",smooth
631,ALS_B,ODF2,0.3,55,"propanoate metabolism, Wnt signalling",cardiac
632,ALS_B,MON2,NA,55,"synthesis and degradation of ketone bodies, focal adhesion",smooth
633,ALS_B,PDLIM2,-0.1,50,"focal adhesion, Wnt signalling",cardiac
634,ALS_B,WAC,0.5,87,"cancer pathways, apoptosis",smooth
635,ALS_B,FLCN,-0.2,32,"focal adhesion, citrate cycle",skeletal
636,ALS_B,ATF6,0.4,57,"cancer pathways, synthesis and degradation of ketone bodies",smooth
637,ALS_B,TRAFD1,-0.2,63,"citrate cycle, propanoate metabolism",smooth
638,ALS_B,BICD1,0.9,82,"focal adhesion, pyruvate metabolism",skeletal
639,ALS_B,ANP32A,-0.2,58,"cancer pathways, Wnt signalling",skeletal
640,ALS_B,KDSR,0.3,35,"synthesis and degradation of ketone bodies, fatty acid degradation",cardiac
641,ALS_B,FBXO9,0.1,64,"synthesis and degradation of ketone bodies, MAPK",smooth
642,ALS_B,UBQLN2,0.3,31,"Wnt signalling, synthesis and degradation of ketone bodies",cardiac
643,ALS_B,ZFX,0.5,15,"synthesis and degradation of ketone bodies, propanoate metabolism",cardiac
644,ALS_B,CPLX2,-0.3,64,"fatty acid degradation, fatty acid degradation",smooth
645,ALS_B,CLPX,0.4,56,"Wnt signalling, MAPK",smooth
646,ALS_B,SGCB,0.5,79,"pyruvate metabolism, propanoate metabolism",cardiac
647,ALS_B,SEMA5A,NA,94,"fatty acid degradation, apoptosis",cardiac
648,ALS_B,PTPRB,0.3,63,"pyruvate metabolism, propanoate metabolism",smooth
649,ALS_B,TMEM33,0.7,5,"Wnt signalling, focal adhesion",smooth
650,ALS_B,SMC1A,0.1,72,"MAPK, citrate cycle",skeletal
651,AQM_B,NF1,-0.1,72,"synthesis and degradation of ketone bodies, fatty acid degradation",skeletal
652,AQM_B,UEVLD,0.2,50,"cancer pathways, synthesis and degradation of ketone bodies",cardiac
653,AQM_B,CDC37L1,0.2,70,"focal adhesion, synthesis and degradation of ketone bodies",smooth
654,AQM_B,HOXD10,NA,75,"fatty acid degradation, apoptosis",smooth
655,AQM_B,NNT,-0.5,14,"MAPK, focal adhesion",skeletal
656,AQM_B,HUWE1,0.2,52,"apoptosis, pyruvate metabolism",skeletal
657,AQM_B,GJA5,-0.2,20,"pyruvate metabolism, fatty acid degradation",skeletal
658,AQM_B,SPCS3,0.4,74,"focal adhesion, propanoate metabolism",smooth
659,AQM_B,DOT1L,NA,67,"apoptosis, synthesis and degradation of ketone bodies",cardiac
660,AQM_B,ATP6V0E1,0.8,33,"cancer pathways, MAPK",smooth
661,AQM_B,XAF1,0.1,43,"cancer pathways, synthesis and degradation of ketone bodies",cardiac
662,AQM_B,MAFG,NA,81,"apoptosis, focal adhesion",cardiac
663,AQM_B,AAK1,0.9,23,"pyruvate metabolism, fatty acid degradation",skeletal
664,AQM_B,TM2D3,NA,24,"cancer pathways, cancer pathways",smooth
665,AQM_B,SSR3,0.7,94,"citrate cycle, fatty acid degradation",smooth
666,AQM_B,ZNF281,0.4,96,"fatty acid degradation, focal adhesion",skeletal
667,AQM_B,JAM2,-0.1,92,"pyruvate metabolism, focal adhesion",cardiac
668,AQM_B,CDC23,0.2,90,"focal adhesion, propanoate metabolism",cardiac
669,AQM_B,PLN,-1.3,61,"synthesis and degradation of ketone bodies, apoptosis",smooth
670,AQM_B,PGP,-0.7,42,"propanoate metabolism, Wnt signalling",cardiac
671,AQM_B,HYI,-0.1,60,"focal adhesion, focal adhesion",cardiac
672,AQM_B,IMPACT,0.6,38,"citrate cycle, Wnt signalling",cardiac
673,AQM_B,C2orf49,0.4,62,"synthesis and degradation of ketone bodies, citrate cycle",smooth
674,AQM_B,HDAC11,-0.6,72,"citrate cycle, Wnt signalling",smooth
675,AQM_B,CCN4,-0.3,39,"Wnt signalling, cancer pathways",smooth
676,AQM_B,MKLN1,1.1,51,"focal adhesion, cancer pathways",skeletal
677,AQM_B,GPRC5B,-0.3,56,"pyruvate metabolism, propanoate metabolism",skeletal
678,AQM_B,RPS6KB1,0.8,12,"citrate cycle, Wnt signalling",smooth
679,AQM_B,PSMA3,-0.2,63,"Wnt signalling, citrate cycle",smooth
680,AQM_B,JARID2,-0.3,96,"Wnt signalling, propanoate metabolism",cardiac
681,AQM_B,ODF2,0.6,73,"pyruvate metabolism, apoptosis",skeletal
682,AQM_B,MON2,-0.2,22,"MAPK, apoptosis",cardiac
683,AQM_B,PDLIM2,-0.1,2,"pyruvate metabolism, MAPK",cardiac
684,AQM_B,WAC,1,37,"synthesis and degradation of ketone bodies, pyruvate metabolism",smooth
685,AQM_B,FLCN,0.1,15,"apoptosis, MAPK",smooth
686,AQM_B,ATF6,0.4,55,"cancer pathways, synthesis and degradation of ketone bodies",skeletal
687,AQM_B,TRAFD1,-0.1,28,"MAPK, apoptosis",smooth
688,AQM_B,BICD1,0.2,77,"pyruvate metabolism, fatty acid degradation",cardiac
689,AQM_B,ANP32A,NA,36,"cancer pathways, focal adhesion",cardiac
690,AQM_B,KDSR,0.6,60,"citrate cycle, MAPK",cardiac
691,AQM_B,FBXO9,-0.3,73,"cancer pathways, synthesis and degradation of ketone bodies",smooth
692,AQM_B,UBQLN2,0.2,93,"apoptosis, pyruvate metabolism",smooth
693,AQM_B,ZFX,0.5,56,"apoptosis, citrate cycle",smooth
694,AQM_B,CPLX2,NA,31,"focal adhesion, synthesis and degradation of ketone bodies",cardiac
695,AQM_B,CLPX,0.2,13,"propanoate metabolism, propanoate metabolism",cardiac
696,AQM_B,SGCB,0.2,91,"apoptosis, MAPK",cardiac
697,AQM_B,SEMA5A,-0.2,50,"fatty acid degradation, synthesis and degradation of ketone bodies",cardiac
698,AQM_B,PTPRB,NA,30,"apoptosis, fatty acid degradation",cardiac
699,AQM_B,TMEM33,0.8,90,"Wnt signalling, apoptosis",cardiac
700,AQM_B,SMC1A,0.1,70,"apoptosis, propanoate metabolism",skeletal
701,BMD_B,NF1,NA,64,"citrate cycle, Wnt signalling",smooth
702,BMD_B,UEVLD,0.1,33,"apoptosis, pyruvate metabolism",smooth
703,BMD_B,CDC37L1,0.2,55,"citrate cycle, MAPK",skeletal
704,BMD_B,HOXD10,-0.2,86,"synthesis and degradation of ketone bodies, apoptosis",skeletal
705,BMD_B,NNT,-0.8,50,"citrate cycle, MAPK",smooth
706,BMD_B,HUWE1,NA,56,"Wnt signalling, citrate cycle",skeletal
707,BMD_B,GJA5,0.3,96,"synthesis and degradation of ketone bodies, Wnt signalling",cardiac
708,BMD_B,SPCS3,0.2,13,"pyruvate metabolism, Wnt signalling",skeletal
709,BMD_B,DOT1L,0.1,75,"fatty acid degradation, focal adhesion",smooth
710,BMD_B,ATP6V0E1,0.5,53,"Wnt signalling, MAPK",cardiac
711,BMD_B,XAF1,-0.1,50,"cancer pathways, cancer pathways",cardiac
712,BMD_B,MAFG,0.2,74,"Wnt signalling, pyruvate metabolism",smooth
713,BMD_B,AAK1,0.5,28,"synthesis and degradation of ketone bodies, synthesis and degradation of ketone bodies",smooth
714,BMD_B,TM2D3,0.1,29,"Wnt signalling, synthesis and degradation of ketone bodies",smooth
715,BMD_B,SSR3,0.1,75,"focal adhesion, synthesis and degradation of ketone bodies",cardiac
716,BMD_B,ZNF281,-0.1,15,"citrate cycle, citrate cycle",smooth
717,BMD_B,JAM2,0.3,98,"apoptosis, propanoate metabolism",cardiac
718,BMD_B,CDC23,NA,93,"cancer pathways, cancer pathways",smooth
719,BMD_B,PLN,-1.1,52,"cancer pathways, synthesis and degradation of ketone bodies",smooth
720,BMD_B,PGP,-0.4,67,"cancer pathways, Wnt signalling",skeletal
721,BMD_B,HYI,0.1,10,"MAPK, focal adhesion",smooth
722,BMD_B,IMPACT,-0.1,43,"Wnt signalling, synthesis and degradation of ketone bodies",cardiac
723,BMD_B,C2orf49,-0.2,45,"cancer pathways, Wnt signalling",smooth
724,BMD_B,HDAC11,-0.2,56,"propanoate metabolism, fatty acid degradation",skeletal
725,BMD_B,CCN4,-0.1,81,"Wnt signalling, cancer pathways",cardiac
726,BMD_B,MKLN1,-0.4,14,"Wnt signalling, fatty acid degradation",cardiac
727,BMD_B,GPRC5B,0.3,78,"Wnt signalling, propanoate metabolism",skeletal
728,BMD_B,RPS6KB1,-0.3,2,"propanoate metabolism, synthesis and degradation of ketone bodies",skeletal
729,BMD_B,PSMA3,-0.2,88,"fatty acid degradation, MAPK",cardiac
730,BMD_B,JARID2,-0.1,58,"cancer pathways, propanoate metabolism",skeletal
731,BMD_B,ODF2,0.2,70,"synthesis and degradation of ketone bodies, cancer pathways",skeletal
732,BMD_B,MON2,NA,25,"Wnt signalling, cancer pathways",cardiac
733,BMD_B,PDLIM2,0.1,45,"propanoate metabolism, cancer pathways",skeletal
734,BMD_B,WAC,-0.1,94,"Wnt signalling, pyruvate metabolism",cardiac
735,BMD_B,FLCN,-0.1,24,"MAPK, citrate cycle",smooth
736,BMD_B,ATF6,0.4,40,"Wnt signalling, propanoate metabolism",skeletal
737,BMD_B,TRAFD1,-0.2,38,"fatty acid degradation, synthesis and degradation of ketone bodies",skeletal
738,BMD_B,BICD1,0.7,33,"MAPK, cancer pathways",skeletal
739,BMD_B,ANP32A,0.1,91,"fatty acid degradation, Wnt signalling",skeletal
740,BMD_B,KDSR,0.3,45,"cancer pathways, focal adhesion",cardiac
741,BMD_B,FBXO9,NA,76,"propanoate metabolism, synthesis and degradation of ketone bodies",smooth
742,BMD_B,UBQLN2,NA,93,"Wnt signalling, pyruvate metabolism",smooth
743,BMD_B,ZFX,-0.1,70,"focal adhesion, apoptosis",smooth
744,BMD_B,CPLX2,NA,31,"MAPK, propanoate metabolism",cardiac
745,BMD_B,CLPX,-0.2,66,"focal adhesion, cancer pathways",cardiac
746,BMD_B,SGCB,NA,92,"Wnt signalling, apoptosis",skeletal
747,BMD_B,SEMA5A,-0.1,12,"focal adhesion, fatty acid degradation",skeletal
748,BMD_B,PTPRB,0.2,88,"focal adhesion, fatty acid degradation",skeletal
749,BMD_B,TMEM33,0.2,6,"fatty acid degradation, pyruvate metabolism",skeletal
750,BMD_B,SMC1A,-0.2,60,"propanoate metabolism, propanoate metabolism",smooth
751,DMD_B,NF1,0.1,92,"MAPK, cancer pathways",cardiac
752,DMD_B,UEVLD,0.1,88,"pyruvate metabolism, focal adhesion",cardiac
753,DMD_B,CDC37L1,-0.4,17,"pyruvate metabolism, synthesis and degradation of ketone bodies",skeletal
754,DMD_B,HOXD10,-0.1,94,"focal adhesion, citrate cycle",smooth
755,DMD_B,NNT,-0.6,76,"apoptosis, fatty acid degradation",cardiac
756,DMD_B,HUWE1,NA,4,"fatty acid degradation, focal adhesion",smooth
757,DMD_B,GJA5,0.1,78,"MAPK, propanoate metabolism",smooth
758,DMD_B,SPCS3,0.2,35,"pyruvate metabolism, propanoate metabolism",cardiac
759,DMD_B,DOT1L,NA,50,"fatty acid degradation, citrate cycle",cardiac
760,DMD_B,ATP6V0E1,0.6,66,"focal adhesion, cancer pathways",cardiac
761,DMD_B,XAF1,0.7,83,"apoptosis, MAPK",cardiac
762,DMD_B,MAFG,-0.2,68,"fatty acid degradation, pyruvate metabolism",cardiac
763,DMD_B,AAK1,0.4,73,"cancer pathways, Wnt signalling",skeletal
764,DMD_B,TM2D3,NA,22,"citrate cycle, synthesis and degradation of ketone bodies",smooth
765,DMD_B,SSR3,0.4,53,"fatty acid degradation, synthesis and degradation of ketone bodies",skeletal
766,DMD_B,ZNF281,NA,1,"focal adhesion, MAPK",smooth
767,DMD_B,JAM2,1.1,76,"apoptosis, focal adhesion",skeletal
768,DMD_B,CDC23,0.2,41,"fatty acid degradation, propanoate metabolism",smooth
769,DMD_B,PLN,-0.7,30,"citrate cycle, pyruvate metabolism",smooth
770,DMD_B,PGP,-0.9,39,"pyruvate metabolism, citrate cycle",cardiac
771,DMD_B,HYI,-0.1,1,"MAPK, Wnt signalling",smooth
772,DMD_B,IMPACT,0.1,52,"Wnt signalling, cancer pathways",cardiac
773,DMD_B,C2orf49,NA,28,"citrate cycle, cancer pathways",cardiac
774,DMD_B,HDAC11,-0.3,87,"apoptosis, propanoate metabolism",smooth
775,DMD_B,CCN4,NA,49,"citrate cycle, cancer pathways",skeletal
776,DMD_B,MKLN1,0.2,48,"MAPK, apoptosis",skeletal
777,DMD_B,GPRC5B,NA,31,"apoptosis, fatty acid degradation",smooth
778,DMD_B,RPS6KB1,0.1,97,"citrate cycle, apoptosis",skeletal
779,DMD_B,PSMA3,-0.2,1,"MAPK, citrate cycle",skeletal
780,DMD_B,JARID2,-0.3,35,"Wnt signalling, Wnt signalling",skeletal
781,DMD_B,ODF2,0.4,100,"fatty acid degradation, apoptosis",skeletal
782,DMD_B,MON2,NA,44,"pyruvate metabolism, citrate cycle",skeletal
783,DMD_B,PDLIM2,-0.1,2,"focal adhesion, apoptosis",smooth
784,DMD_B,WAC,0.5,20,"cancer pathways, Wnt signalling",smooth
785,DMD_B,FLCN,-0.1,71,"Wnt signalling, focal adhesion",smooth
786,DMD_B,ATF6,0.5,24,"citrate cycle, propanoate metabolism",smooth
787,DMD_B,TRAFD1,-0.2,85,"cancer pathways, synthesis and degradation of ketone bodies",skeletal
788,DMD_B,BICD1,0.5,38,"fatty acid degradation, cancer pathways",skeletal
789,DMD_B,ANP32A,NA,4,"citrate cycle, propanoate metabolism",cardiac
790,DMD_B,KDSR,0.6,86,"Wnt signalling, Wnt signalling",cardiac
791,DMD_B,FBXO9,0.1,31,"fatty acid degradation, fatty acid degradation",smooth
792,DMD_B,UBQLN2,0.1,33,"apoptosis, focal adhesion",smooth
793,DMD_B,ZFX,NA,95,"apoptosis, MAPK",skeletal
794,DMD_B,CPLX2,-0.1,30,"fatty acid degradation, propanoate metabolism",smooth
795,DMD_B,CLPX,-0.2,44,"pyruvate metabolism, Wnt signalling",smooth
796,DMD_B,SGCB,-0.2,13,"cancer pathways, synthesis and degradation of ketone bodies",skeletal
797,DMD_B,SEMA5A,0.1,57,"synthesis and degradation of ketone bodies, fatty acid degradation",smooth
798,DMD_B,PTPRB,0.3,78,"pyruvate metabolism, fatty acid degradation",skeletal
799,DMD_B,TMEM33,0.4,87,"fatty acid degradation, apoptosis",smooth
800,DMD_B,SMC1A,-0.1,96,"citrate cycle, MAPK",smooth
801,EDMD.AD_B,NF1,0.2,3,"Wnt signalling, apoptosis",cardiac
802,EDMD.AD_B,UEVLD,0.1,47,"Wnt signalling, Wnt signalling",smooth
803,EDMD.AD_B,CDC37L1,0.4,46,"propanoate metabolism, apoptosis",skeletal
804,EDMD.AD_B,HOXD10,-0.1,13,"Wnt signalling, fatty acid degradation",skeletal
805,EDMD.AD_B,NNT,-0.2,0,"cancer pathways, cancer pathways",smooth
806,EDMD.AD_B,HUWE1,NA,82,"pyruvate metabolism, propanoate metabolism",smooth
807,EDMD.AD_B,GJA5,-0.1,51,"MAPK, Wnt signalling",cardiac
808,EDMD.AD_B,SPCS3,NA,81,"pyruvate metabolism, synthesis and degradation of ketone bodies",skeletal
809,EDMD.AD_B,DOT1L,0.2,93,"Wnt signalling, citrate cycle",skeletal
810,EDMD.AD_B,ATP6V0E1,0.8,22,"fatty acid degradation, MAPK",smooth
811,EDMD.AD_B,XAF1,0.3,75,"Wnt signalling, apoptosis",skeletal
812,EDMD.AD_B,MAFG,-0.3,23,"Wnt signalling, pyruvate metabolism",skeletal
813,EDMD.AD_B,AAK1,0.5,87,"synthesis and degradation of ketone bodies, Wnt signalling",skeletal
814,EDMD.AD_B,TM2D3,NA,27,"fatty acid degradation, focal adhesion",skeletal
815,EDMD.AD_B,SSR3,0.3,85,"focal adhesion, focal adhesion",skeletal
816,EDMD.AD_B,ZNF281,0.2,5,"focal adhesion, apoptosis",skeletal
817,EDMD.AD_B,JAM2,0.7,68,"focal adhesion, cancer pathways",skeletal
818,EDMD.AD_B,CDC23,0.4,74,"focal adhesion, MAPK",skeletal
819,EDMD.AD_B,PLN,-0.6,29,"citrate cycle, cancer pathways",skeletal
820,EDMD.AD_B,PGP,-0.7,74,"apoptosis, MAPK",cardiac
821,EDMD.AD_B,HYI,NA,77,"fatty acid degradation, citrate cycle",smooth
822,EDMD.AD_B,IMPACT,NA,91,"Wnt signalling, synthesis and degradation of ketone bodies",smooth
823,EDMD.AD_B,C2orf49,0.1,87,"fatty acid degradation, apoptosis",skeletal
824,EDMD.AD_B,HDAC11,-0.5,49,"cancer pathways, cancer pathways",skeletal
825,EDMD.AD_B,CCN4,NA,93,"fatty acid degradation, Wnt signalling",smooth
826,EDMD.AD_B,MKLN1,0.6,21,"MAPK, fatty acid degradation",smooth
827,EDMD.AD_B,GPRC5B,-0.3,56,"focal adhesion, MAPK",skeletal
828,EDMD.AD_B,RPS6KB1,0.3,83,"fatty acid degradation, synthesis and degradation of ketone bodies",skeletal
829,EDMD.AD_B,PSMA3,0.1,59,"propanoate metabolism, focal adhesion",smooth
830,EDMD.AD_B,JARID2,-0.2,54,"apoptosis, fatty acid degradation",skeletal
831,EDMD.AD_B,ODF2,0.4,72,"MAPK, citrate cycle",cardiac
832,EDMD.AD_B,MON2,NA,11,"fatty acid degradation, Wnt signalling",cardiac
833,EDMD.AD_B,PDLIM2,-0.2,29,"focal adhesion, fatty acid degradation",cardiac
834,EDMD.AD_B,WAC,0.6,12,"Wnt signalling, citrate cycle",cardiac
835,EDMD.AD_B,FLCN,-0.2,45,"cancer pathways, apoptosis",skeletal
836,EDMD.AD_B,ATF6,0.5,15,"propanoate metabolism, MAPK",cardiac
837,EDMD.AD_B,TRAFD1,0.1,87,"propanoate metabolism, apoptosis",smooth
838,EDMD.AD_B,BICD1,0.7,70,"citrate cycle, apoptosis",cardiac
839,EDMD.AD_B,ANP32A,-0.1,94,"pyruvate metabolism, Wnt signalling",cardiac
840,EDMD.AD_B,KDSR,0.8,70,"pyruvate metabolism, apoptosis",smooth
841,EDMD.AD_B,FBXO9,NA,13,"focal adhesion, synthesis and degradation of ketone bodies",skeletal
842,EDMD.AD_B,UBQLN2,NA,79,"propanoate metabolism, propanoate metabolism",skeletal
843,EDMD.AD_B,ZFX,0.3,50,"focal adhesion, Wnt signalling",skeletal
844,EDMD.AD_B,CPLX2,-0.2,21,"cancer pathways, propanoate metabolism",skeletal
845,EDMD.AD_B,CLPX,NA,37,"fatty acid degradation, MAPK",cardiac
846,EDMD.AD_B,SGCB,-0.1,21,"citrate cycle, citrate cycle",smooth
847,EDMD.AD_B,SEMA5A,0.2,5,"fatty acid degradation, Wnt signalling",cardiac
848,EDMD.AD_B,PTPRB,0.3,83,"propanoate metabolism, Wnt signalling",cardiac
849,EDMD.AD_B,TMEM33,0.6,40,"fatty acid degradation, cancer pathways",skeletal
850,EDMD.AD_B,SMC1A,NA,97,"synthesis and degradation of ketone bodies, focal adhesion",smooth
851,EDMD.XR_B,NF1,NA,68,"focal adhesion, MAPK",cardiac
852,EDMD.XR_B,UEVLD,NA,39,"synthesis and degradation of ketone bodies, cancer pathways",cardiac
853,EDMD.XR_B,CDC37L1,0.6,70,"apoptosis, apoptosis",cardiac
854,EDMD.XR_B,HOXD10,NA,73,"pyruvate metabolism, pyruvate metabolism",smooth
855,EDMD.XR_B,NNT,0.2,26,"focal adhesion, synthesis and degradation of ketone bodies",cardiac
856,EDMD.XR_B,HUWE1,NA,92,"synthesis and degradation of ketone bodies, apoptosis",cardiac
857,EDMD.XR_B,GJA5,-0.2,49,"citrate cycle, MAPK",skeletal
858,EDMD.XR_B,SPCS3,0.2,38,"pyruvate metabolism, citrate cycle",smooth
859,EDMD.XR_B,DOT1L,NA,2,"fatty acid degradation, focal adhesion",smooth
860,EDMD.XR_B,ATP6V0E1,0.5,80,"Wnt signalling, focal adhesion",skeletal
861,EDMD.XR_B,XAF1,0.1,16,"synthesis and degradation of ketone bodies, citrate cycle",skeletal
862,EDMD.XR_B,MAFG,NA,64,"pyruvate metabolism, Wnt signalling",smooth
863,EDMD.XR_B,AAK1,0.5,73,"MAPK, fatty acid degradation",skeletal
864,EDMD.XR_B,TM2D3,0.3,78,"fatty acid degradation, propanoate metabolism",cardiac
865,EDMD.XR_B,SSR3,NA,32,"pyruvate metabolism, fatty acid degradation",cardiac
866,EDMD.XR_B,ZNF281,0.3,17,"focal adhesion, synthesis and degradation of ketone bodies",skeletal
867,EDMD.XR_B,JAM2,NA,61,"citrate cycle, apoptosis",skeletal
868,EDMD.XR_B,CDC23,NA,43,"cancer pathways, apoptosis",skeletal
869,EDMD.XR_B,PLN,NA,88,"focal adhesion, citrate cycle",smooth
870,EDMD.XR_B,PGP,-0.1,57,"fatty acid degradation, cancer pathways",smooth
871,EDMD.XR_B,HYI,-0.2,28,"apoptosis, focal adhesion",cardiac
872,EDMD.XR_B,IMPACT,-0.1,25,"cancer pathways, MAPK",skeletal
873,EDMD.XR_B,C2orf49,0.2,15,"pyruvate metabolism, propanoate metabolism",smooth
874,EDMD.XR_B,HDAC11,-0.1,81,"propanoate metabolism, synthesis and degradation of ketone bodies",smooth
875,EDMD.XR_B,CCN4,NA,28,"synthesis and degradation of ketone bodies, MAPK",smooth
876,EDMD.XR_B,MKLN1,0.3,99,"pyruvate metabolism, propanoate metabolism",smooth
877,EDMD.XR_B,GPRC5B,0.1,78,"Wnt signalling, fatty acid degradation",smooth
878,EDMD.XR_B,RPS6KB1,0.2,58,"pyruvate metabolism, apoptosis",skeletal
879,EDMD.XR_B,PSMA3,NA,92,"MAPK, cancer pathways",smooth
880,EDMD.XR_B,JARID2,-0.3,37,"focal adhesion, apoptosis",smooth
881,EDMD.XR_B,ODF2,NA,54,"Wnt signalling, pyruvate metabolism",cardiac
882,EDMD.XR_B,MON2,NA,88,"focal adhesion, cancer pathways",skeletal
883,EDMD.XR_B,PDLIM2,-0.2,53,"synthesis and degradation of ketone bodies, apoptosis",cardiac
884,EDMD.XR_B,WAC,0.2,17,"synthesis and degradation of ketone bodies, cancer pathways",smooth
885,EDMD.XR_B,FLCN,-0.2,96,"propanoate metabolism, fatty acid degradation",skeletal
886,EDMD.XR_B,ATF6,0.4,61,"fatty acid degradation, apoptosis",skeletal
887,EDMD.XR_B,TRAFD1,NA,23,"propanoate metabolism, apoptosis",smooth
888,EDMD.XR_B,BICD1,0.6,1,"propanoate metabolism, citrate cycle",cardiac
889,EDMD.XR_B,ANP32A,-0.2,100,"propanoate metabolism, propanoate metabolism",cardiac
890,EDMD.XR_B,KDSR,0.2,67,"MAPK, Wnt signalling",cardiac
891,EDMD.XR_B,FBXO9,0.2,81,"fatty acid degradation, pyruvate metabolism",skeletal
892,EDMD.XR_B,UBQLN2,NA,6,"citrate cycle, pyruvate metabolism",skeletal
893,EDMD.XR_B,ZFX,0.2,98,"apoptosis, Wnt signalling",smooth
894,EDMD.XR_B,CPLX2,NA,48,"focal adhesion, MAPK",smooth
895,EDMD.XR_B,CLPX,0.2,42,"Wnt signalling, MAPK",smooth
896,EDMD.XR_B,SGCB,0.1,92,"synthesis and degradation of ketone bodies, fatty acid degradation",smooth
897,EDMD.XR_B,SEMA5A,NA,16,"fatty acid degradation, MAPK",cardiac
898,EDMD.XR_B,PTPRB,-0.1,25,"propanoate metabolism, cancer pathways",cardiac
899,EDMD.XR_B,TMEM33,0.4,89,"citrate cycle, focal adhesion",cardiac
900,EDMD.XR_B,SMC1A,NA,85,"Wnt signalling, synthesis and degradation of ketone bodies",skeletal
901,FSHD_B,NF1,NA,62,"Wnt signalling, fatty acid degradation",skeletal
902,FSHD_B,UEVLD,0.5,44,"citrate cycle, cancer pathways",skeletal
903,FSHD_B,CDC37L1,0.4,54,"pyruvate metabolism, apoptosis",cardiac
904,FSHD_B,HOXD10,-0.1,85,"synthesis and degradation of ketone bodies, propanoate metabolism",smooth
905,FSHD_B,NNT,0.3,15,"focal adhesion, propanoate metabolism",skeletal
906,FSHD_B,HUWE1,0.1,45,"focal adhesion, cancer pathways",smooth
907,FSHD_B,GJA5,-0.2,32,"pyruvate metabolism, citrate cycle",skeletal
908,FSHD_B,SPCS3,NA,43,"Wnt signalling, apoptosis",smooth
909,FSHD_B,DOT1L,0.4,92,"fatty acid degradation, propanoate metabolism",cardiac
910,FSHD_B,ATP6V0E1,0.7,85,"focal adhesion, Wnt signalling",cardiac
911,FSHD_B,XAF1,0.5,97,"citrate cycle, apoptosis",cardiac
912,FSHD_B,MAFG,-0.2,44,"synthesis and degradation of ketone bodies, propanoate metabolism",skeletal
913,FSHD_B,AAK1,0.6,52,"fatty acid degradation, MAPK",skeletal
914,FSHD_B,TM2D3,0.2,94,"Wnt signalling, propanoate metabolism",skeletal
915,FSHD_B,SSR3,0.5,35,"citrate cycle, Wnt signalling",cardiac
916,FSHD_B,ZNF281,0.4,38,"fatty acid degradation, citrate cycle",cardiac
917,FSHD_B,JAM2,0.6,56,"cancer pathways, focal adhesion",cardiac
918,FSHD_B,CDC23,0.1,22,"synthesis and degradation of ketone bodies, citrate cycle",smooth
919,FSHD_B,PLN,0.2,29,"citrate cycle, propanoate metabolism",cardiac
920,FSHD_B,PGP,0.1,41,"synthesis and degradation of ketone bodies, citrate cycle",skeletal
921,FSHD_B,HYI,NA,30,"apoptosis, citrate cycle",smooth
922,FSHD_B,IMPACT,0.2,88,"cancer pathways, Wnt signalling",skeletal
923,FSHD_B,C2orf49,0.6,70,"citrate cycle, cancer pathways",smooth
924,FSHD_B,HDAC11,NA,1,"pyruvate metabolism, focal adhesion",skeletal
925,FSHD_B,CCN4,-0.3,59,"fatty acid degradation, synthesis and degradation of ketone bodies",smooth
926,FSHD_B,MKLN1,0.6,16,"focal adhesion, apoptosis",skeletal
927,FSHD_B,GPRC5B,0.4,5,"Wnt signalling, fatty acid degradation",skeletal
928,FSHD_B,RPS6KB1,0.5,15,"focal adhesion, synthesis and degradation of ketone bodies",smooth
929,FSHD_B,PSMA3,NA,6,"pyruvate metabolism, apoptosis",skeletal
930,FSHD_B,JARID2,-0.1,48,"propanoate metabolism, MAPK",cardiac
931,FSHD_B,ODF2,0.1,82,"focal adhesion, Wnt signalling",cardiac
932,FSHD_B,MON2,-0.1,99,"apoptosis, synthesis and degradation of ketone bodies",smooth
933,FSHD_B,PDLIM2,-0.1,22,"cancer pathways, synthesis and degradation of ketone bodies",skeletal
934,FSHD_B,WAC,0.8,79,"pyruvate metabolism, cancer pathways",smooth
935,FSHD_B,FLCN,-0.2,64,"cancer pathways, MAPK",cardiac
936,FSHD_B,ATF6,0.5,24,"focal adhesion, apoptosis",smooth
937,FSHD_B,TRAFD1,-0.1,5,"Wnt signalling, citrate cycle",cardiac
938,FSHD_B,BICD1,0.4,48,"fatty acid degradation, citrate cycle",cardiac
939,FSHD_B,ANP32A,NA,5,"MAPK, propanoate metabolism",skeletal
940,FSHD_B,KDSR,0.9,70,"cancer pathways, synthesis and degradation of ketone bodies",smooth
941,FSHD_B,FBXO9,-0.1,1,"MAPK, apoptosis",smooth
942,FSHD_B,UBQLN2,0.3,9,"apoptosis, pyruvate metabolism",smooth
943,FSHD_B,ZFX,0.4,47,"cancer pathways, MAPK",smooth
944,FSHD_B,CPLX2,-0.2,45,"focal adhesion, synthesis and degradation of ketone bodies",cardiac
945,FSHD_B,CLPX,0.2,32,"citrate cycle, cancer pathways",cardiac
946,FSHD_B,SGCB,0.3,71,"cancer pathways, fatty acid degradation",skeletal
947,FSHD_B,SEMA5A,-0.1,75,"focal adhesion, citrate cycle",skeletal
948,FSHD_B,PTPRB,0.6,57,"synthesis and degradation of ketone bodies, pyruvate metabolism",skeletal
949,FSHD_B,TMEM33,0.4,100,"focal adhesion, apoptosis",smooth
950,FSHD_B,SMC1A,-0.1,49,"citrate cycle, focal adhesion",cardiac
951,HSP_B,NF1,NA,51,"synthesis and degradation of ketone bodies, synthesis and degradation of ketone bodies",skeletal
952,HSP_B,UEVLD,NA,48,"Wnt signalling, apoptosis",cardiac
953,HSP_B,CDC37L1,-0.8,99,"fatty acid degradation, pyruvate metabolism",smooth
954,HSP_B,HOXD10,NA,63,"citrate cycle, Wnt signalling",cardiac
955,HSP_B,NNT,-0.8,64,"propanoate metabolism, pyruvate metabolism",smooth
956,HSP_B,HUWE1,NA,100,"Wnt signalling, citrate cycle",smooth
957,HSP_B,GJA5,0.3,42,"citrate cycle, focal adhesion",smooth
958,HSP_B,SPCS3,NA,100,"Wnt signalling, Wnt signalling",skeletal
959,HSP_B,DOT1L,NA,39,"focal adhesion, focal adhesion",skeletal
960,HSP_B,ATP6V0E1,-0.4,54,"focal adhesion, propanoate metabolism",cardiac
961,HSP_B,XAF1,-0.3,66,"synthesis and degradation of ketone bodies, citrate cycle",smooth
962,HSP_B,MAFG,0.4,85,"Wnt signalling, apoptosis",smooth
963,HSP_B,AAK1,-0.1,48,"Wnt signalling, fatty acid degradation",cardiac
964,HSP_B,TM2D3,-0.2,94,"fatty acid degradation, apoptosis",cardiac
965,HSP_B,SSR3,-0.4,4,"synthesis and degradation of ketone bodies, cancer pathways",skeletal
966,HSP_B,ZNF281,-0.2,60,"cancer pathways, Wnt signalling",cardiac
967,HSP_B,JAM2,-0.4,69,"MAPK, citrate cycle",skeletal
968,HSP_B,CDC23,NA,73,"MAPK, citrate cycle",smooth
969,HSP_B,PLN,-0.7,18,"pyruvate metabolism, focal adhesion",cardiac
970,HSP_B,PGP,0.3,0,"pyruvate metabolism, propanoate metabolism",cardiac
971,HSP_B,HYI,0.5,72,"MAPK, propanoate metabolism",smooth
972,HSP_B,IMPACT,-0.6,26,"MAPK, MAPK",smooth
973,HSP_B,C2orf49,0.1,65,"apoptosis, focal adhesion",cardiac
974,HSP_B,HDAC11,0.6,44,"Wnt signalling, citrate cycle",skeletal
975,HSP_B,CCN4,NA,69,"pyruvate metabolism, MAPK",skeletal
976,HSP_B,MKLN1,-0.7,72,"propanoate metabolism, synthesis and degradation of ketone bodies",skeletal
977,HSP_B,GPRC5B,-0.1,29,"apoptosis, synthesis and degradation of ketone bodies",skeletal
978,HSP_B,RPS6KB1,-0.8,23,"synthesis and degradation of ketone bodies, apoptosis",smooth
979,HSP_B,PSMA3,NA,91,"cancer pathways, MAPK",cardiac
980,HSP_B,JARID2,-0.1,66,"apoptosis, synthesis and degradation of ketone bodies",smooth
981,HSP_B,ODF2,NA,38,"propanoate metabolism, cancer pathways",skeletal
982,HSP_B,MON2,NA,69,"MAPK, focal adhesion",cardiac
983,HSP_B,PDLIM2,NA,0,"cancer pathways, synthesis and degradation of ketone bodies",smooth
984,HSP_B,WAC,-0.4,57,"fatty acid degradation, citrate cycle",cardiac
985,HSP_B,FLCN,0.3,31,"cancer pathways, apoptosis",smooth
986,HSP_B,ATF6,-0.2,98,"fatty acid degradation, MAPK",cardiac
987,HSP_B,TRAFD1,NA,77,"synthesis and degradation of ketone bodies, citrate cycle",skeletal
988,HSP_B,BICD1,-0.3,6,"citrate cycle, citrate cycle",smooth
989,HSP_B,ANP32A,0.3,90,"Wnt signalling, pyruvate metabolism",skeletal
990,HSP_B,KDSR,-0.2,8,"propanoate metabolism, MAPK",cardiac
991,HSP_B,FBXO9,-0.3,60,"cancer pathways, synthesis and degradation of ketone bodies",smooth
992,HSP_B,UBQLN2,NA,28,"pyruvate metabolism, propanoate metabolism",cardiac
993,HSP_B,ZFX,-0.2,76,"apoptosis, apoptosis",cardiac
994,HSP_B,CPLX2,NA,86,"synthesis and degradation of ketone bodies, apoptosis",skeletal
995,HSP_B,CLPX,-0.3,94,"Wnt signalling, propanoate metabolism",smooth
996,HSP_B,SGCB,-0.1,21,"synthesis and degradation of ketone bodies, apoptosis",skeletal
997,HSP_B,SEMA5A,NA,80,"synthesis and degradation of ketone bodies, apoptosis",smooth
998,HSP_B,PTPRB,-0.5,58,"focal adhesion, propanoate metabolism",cardiac
999,HSP_B,TMEM33,-0.3,11,"focal adhesion, synthesis and degradation of ketone bodies",cardiac
1000,HSP_B,SMC1A,NA,31,"pyruvate metabolism, propanoate metabolism",cardiac
1001,JDM_B,NF1,0.1,42,"propanoate metabolism, synthesis and degradation of ketone bodies",skeletal
1002,JDM_B,UEVLD,0.3,54,"Wnt signalling, cancer pathways",skeletal
1003,JDM_B,CDC37L1,0.5,4,"MAPK, focal adhesion",cardiac
1004,JDM_B,HOXD10,NA,86,"fatty acid degradation, focal adhesion",smooth
1005,JDM_B,NNT,-0.3,80,"citrate cycle, citrate cycle",smooth
1006,JDM_B,HUWE1,0.1,77,"Wnt signalling, propanoate metabolism",smooth
1007,JDM_B,GJA5,-0.3,71,"fatty acid degradation, MAPK",smooth
1008,JDM_B,SPCS3,0.6,73,"citrate cycle, propanoate metabolism",cardiac
1009,JDM_B,DOT1L,0.8,24,"Wnt signalling, Wnt signalling",cardiac
1010,JDM_B,ATP6V0E1,0.9,59,"citrate cycle, Wnt signalling",smooth
1011,JDM_B,XAF1,3.4,73,"apoptosis, pyruvate metabolism",skeletal
1012,JDM_B,MAFG,-0.4,56,"synthesis and degradation of ketone bodies, focal adhesion",skeletal
1013,JDM_B,AAK1,0.7,91,"synthesis and degradation of ketone bodies, synthesis and degradation of ketone bodies",skeletal
1014,JDM_B,TM2D3,-0.3,82,"citrate cycle, fatty acid degradation",smooth
1015,JDM_B,SSR3,0.9,19,"fatty acid degradation, fatty acid degradation",skeletal
1016,JDM_B,ZNF281,0.8,33,"propanoate metabolism, pyruvate metabolism",cardiac
1017,JDM_B,JAM2,0.8,51,"cancer pathways, fatty acid degradation",smooth
1018,JDM_B,CDC23,0.3,36,"propanoate metabolism, focal adhesion",skeletal
1019,JDM_B,PLN,-0.3,14,"propanoate metabolism, MAPK",skeletal
1020,JDM_B,PGP,-0.2,26,"cancer pathways, pyruvate metabolism",smooth
1021,JDM_B,HYI,-0.2,72,"focal adhesion, Wnt signalling",smooth
1022,JDM_B,IMPACT,0.4,61,"synthesis and degradation of ketone bodies, cancer pathways",smooth
1023,JDM_B,C2orf49,0.6,59,"pyruvate metabolism, citrate cycle",cardiac
1024,JDM_B,HDAC11,-0.2,41,"propanoate metabolism, focal adhesion",smooth
1025,JDM_B,CCN4,-0.3,65,"focal adhesion, pyruvate metabolism",smooth
1026,JDM_B,MKLN1,0.9,73,"Wnt signalling, propanoate metabolism",smooth
1027,JDM_B,GPRC5B,NA,3,"MAPK, synthesis and degradation of ketone bodies",skeletal
1028,JDM_B,RPS6KB1,0.8,69,"pyruvate metabolism, pyruvate metabolism",skeletal
1029,JDM_B,PSMA3,-0.1,48,"apoptosis, synthesis and degradation of ketone bodies",smooth
1030,JDM_B,JARID2,-0.2,40,"propanoate metabolism, MAPK",skeletal
1031,JDM_B,ODF2,0.4,2,"citrate cycle, propanoate metabolism",cardiac
1032,JDM_B,MON2,-0.1,14,"pyruvate metabolism, MAPK",smooth
1033,JDM_B,PDLIM2,-0.2,52,"citrate cycle, pyruvate metabolism",cardiac
1034,JDM_B,WAC,1.3,10,"propanoate metabolism, pyruvate metabolism",skeletal
1035,JDM_B,FLCN,NA,42,"MAPK, pyruvate metabolism",cardiac
1036,JDM_B,ATF6,0.7,42,"focal adhesion, fatty acid degradation",skeletal
1037,JDM_B,TRAFD1,0.2,91,"Wnt signalling, citrate cycle",smooth
1038,JDM_B,BICD1,NA,26,"cancer pathways, Wnt signalling",skeletal
1039,JDM_B,ANP32A,-0.1,72,"cancer pathways, citrate cycle",cardiac
1040,JDM_B,KDSR,0.8,75,"propanoate metabolism, fatty acid degradation",skeletal
1041,JDM_B,FBXO9,-0.2,39,"MAPK, MAPK",cardiac
1042,JDM_B,UBQLN2,0.3,7,"MAPK, synthesis and degradation of ketone bodies",smooth
1043,JDM_B,ZFX,0.8,6,"MAPK, synthesis and degradation of ketone bodies",smooth
1044,JDM_B,CPLX2,-0.3,85,"focal adhesion, synthesis and degradation of ketone bodies",smooth
1045,JDM_B,CLPX,0.2,14,"synthesis and degradation of ketone bodies, fatty acid degradation",smooth
1046,JDM_B,SGCB,0.1,80,"Wnt signalling, synthesis and degradation of ketone bodies",cardiac
1047,JDM_B,SEMA5A,-0.1,90,"apoptosis, Wnt signalling",skeletal
1048,JDM_B,PTPRB,0.8,100,"apoptosis, focal adhesion",cardiac
1049,JDM_B,TMEM33,0.6,60,"MAPK, Wnt signalling",cardiac
1050,JDM_B,SMC1A,-0.1,7,"MAPK, pyruvate metabolism",skeletal
1051,LGMD2A_B,NF1,NA,26,"Wnt signalling, pyruvate metabolism",skeletal
1052,LGMD2A_B,UEVLD,-0.1,29,"apoptosis, citrate cycle",cardiac
1053,LGMD2A_B,CDC37L1,-0.2,19,"MAPK, synthesis and degradation of ketone bodies",skeletal
1054,LGMD2A_B,HOXD10,NA,99,"apoptosis, pyruvate metabolism",smooth
1055,LGMD2A_B,NNT,-0.8,4,"synthesis and degradation of ketone bodies, citrate cycle",cardiac
1056,LGMD2A_B,HUWE1,NA,93,"synthesis and degradation of ketone bodies, fatty acid degradation",smooth
1057,LGMD2A_B,GJA5,0.2,92,"pyruvate metabolism, MAPK",cardiac
1058,LGMD2A_B,SPCS3,NA,49,"synthesis and degradation of ketone bodies, Wnt signalling",cardiac
1059,LGMD2A_B,DOT1L,NA,87,"propanoate metabolism, citrate cycle",cardiac
1060,LGMD2A_B,ATP6V0E1,0.1,0,"MAPK, Wnt signalling",skeletal
1061,LGMD2A_B,XAF1,0.2,65,"citrate cycle, MAPK",skeletal
1062,LGMD2A_B,MAFG,0.1,12,"fatty acid degradation, cancer pathways",skeletal
1063,LGMD2A_B,AAK1,0.2,65,"propanoate metabolism, citrate cycle",cardiac
1064,LGMD2A_B,TM2D3,NA,30,"citrate cycle, Wnt signalling",cardiac
1065,LGMD2A_B,SSR3,0.1,53,"propanoate metabolism, pyruvate metabolism",skeletal
1066,LGMD2A_B,ZNF281,-0.1,55,"propanoate metabolism, synthesis and degradation of ketone bodies",skeletal
1067,LGMD2A_B,JAM2,0.4,7,"pyruvate metabolism, Wnt signalling",smooth
1068,LGMD2A_B,CDC23,NA,27,"fatty acid degradation, citrate cycle",smooth
1069,LGMD2A_B,PLN,-1.1,49,"synthesis and degradation of ketone bodies, focal adhesion",smooth
1070,LGMD2A_B,PGP,-0.5,89,"cancer pathways, focal adhesion",cardiac
1071,LGMD2A_B,HYI,0.2,89,"apoptosis, propanoate metabolism",smooth
1072,LGMD2A_B,IMPACT,-0.1,21,"citrate cycle, MAPK",skeletal
1073,LGMD2A_B,C2orf49,-0.1,80,"synthesis and degradation of ketone bodies, fatty acid degradation",cardiac
1074,LGMD2A_B,HDAC11,-0.3,74,"synthesis and degradation of ketone bodies, Wnt signalling",smooth
1075,LGMD2A_B,CCN4,-0.1,59,"Wnt signalling, fatty acid degradation",skeletal
1076,LGMD2A_B,MKLN1,NA,0,"MAPK, citrate cycle",smooth
1077,LGMD2A_B,GPRC5B,0.1,14,"propanoate metabolism, fatty acid degradation",cardiac
1078,LGMD2A_B,RPS6KB1,-0.2,37,"apoptosis, Wnt signalling",skeletal
1079,LGMD2A_B,PSMA3,0.1,18,"fatty acid degradation, pyruvate metabolism",skeletal
1080,LGMD2A_B,JARID2,-0.1,45,"synthesis and degradation of ketone bodies, MAPK",cardiac
1081,LGMD2A_B,ODF2,0.3,87,"pyruvate metabolism, propanoate metabolism",skeletal
1082,LGMD2A_B,MON2,-0.1,13,"focal adhesion, MAPK",smooth
1083,LGMD2A_B,PDLIM2,NA,5,"fatty acid degradation, synthesis and degradation of ketone bodies",cardiac
1084,LGMD2A_B,WAC,0.1,49,"MAPK, citrate cycle",cardiac
1085,LGMD2A_B,FLCN,-0.1,25,"cancer pathways, focal adhesion",skeletal
1086,LGMD2A_B,ATF6,0.3,39,"Wnt signalling, pyruvate metabolism",smooth
1087,LGMD2A_B,TRAFD1,-0.1,96,"propanoate metabolism, citrate cycle",smooth
1088,LGMD2A_B,BICD1,0.3,29,"cancer pathways, pyruvate metabolism",skeletal
1089,LGMD2A_B,ANP32A,0.1,48,"MAPK, fatty acid degradation",smooth
1090,LGMD2A_B,KDSR,0.3,66,"MAPK, focal adhesion",smooth
1091,LGMD2A_B,FBXO9,-0.3,72,"Wnt signalling, synthesis and degradation of ketone bodies",smooth
1092,LGMD2A_B,UBQLN2,NA,33,"cancer pathways, apoptosis",cardiac
1093,LGMD2A_B,ZFX,-0.1,25,"apoptosis, pyruvate metabolism",skeletal
1094,LGMD2A_B,CPLX2,NA,56,"Wnt signalling, cancer pathways",smooth
1095,LGMD2A_B,CLPX,-0.3,8,"citrate cycle, fatty acid degradation",cardiac
1096,LGMD2A_B,SGCB,NA,81,"synthesis and degradation of ketone bodies, fatty acid degradation",cardiac
1097,LGMD2A_B,SEMA5A,-0.1,49,"synthesis and degradation of ketone bodies, synthesis and degradation of ketone bodies",smooth
1098,LGMD2A_B,PTPRB,-0.1,74,"pyruvate metabolism, fatty acid degradation",smooth
1099,LGMD2A_B,TMEM33,0.2,59,"MAPK, fatty acid degradation",cardiac
1100,LGMD2A_B,SMC1A,-0.1,61,"propanoate metabolism, synthesis and degradation of ketone bodies",smooth
1101,LGMD2B_B,NF1,NA,60,"apoptosis, propanoate metabolism",cardiac
1102,LGMD2B_B,UEVLD,NA,17,"MAPK, fatty acid degradation",cardiac
1103,LGMD2B_B,CDC37L1,-0.1,75,"cancer pathways, MAPK",smooth
1104,LGMD2B_B,HOXD10,NA,14,"citrate cycle, MAPK",smooth
1105,LGMD2B_B,NNT,-0.8,58,"citrate cycle, citrate cycle",cardiac
1106,LGMD2B_B,HUWE1,NA,11,"Wnt signalling, synthesis and degradation of ketone bodies",cardiac
1107,LGMD2B_B,GJA5,0.5,93,"focal adhesion, cancer pathways",skeletal
1108,LGMD2B_B,SPCS3,0.2,15,"apoptosis, MAPK",smooth
1109,LGMD2B_B,DOT1L,-0.1,55,"pyruvate metabolism, focal adhesion",smooth
1110,LGMD2B_B,ATP6V0E1,0.2,28,"citrate cycle, focal adhesion",smooth
1111,LGMD2B_B,XAF1,0.1,96,"apoptosis, citrate cycle",smooth
1112,LGMD2B_B,MAFG,0.3,46,"focal adhesion, fatty acid degradation",cardiac
1113,LGMD2B_B,AAK1,0.3,96,"pyruvate metabolism, Wnt signalling",cardiac
1114,LGMD2B_B,TM2D3,NA,28,"apoptosis, Wnt signalling",smooth
1115,LGMD2B_B,SSR3,0.2,49,"pyruvate metabolism, MAPK",skeletal
1116,LGMD2B_B,ZNF281,-0.1,33,"focal adhesion, cancer pathways",smooth
1117,LGMD2B_B,JAM2,0.2,4,"fatty acid degradation, synthesis and degradation of ketone bodies",skeletal
1118,LGMD2B_B,CDC23,NA,92,"citrate cycle, Wnt signalling",skeletal
1119,LGMD2B_B,PLN,-1.1,7,"citrate cycle, MAPK",skeletal
1120,LGMD2B_B,PGP,-0.4,27,"citrate cycle, apoptosis",smooth
1121,LGMD2B_B,HYI,NA,94,"pyruvate metabolism, propanoate metabolism",skeletal
1122,LGMD2B_B,IMPACT,-0.2,14,"pyruvate metabolism, MAPK",skeletal
1123,LGMD2B_B,C2orf49,-0.4,59,"synthesis and degradation of ketone bodies, fatty acid degradation",cardiac
1124,LGMD2B_B,HDAC11,NA,41,"cancer pathways, cancer pathways",smooth
1125,LGMD2B_B,CCN4,-0.1,59,"synthesis and degradation of ketone bodies, propanoate metabolism",smooth
1126,LGMD2B_B,MKLN1,-0.2,6,"MAPK, focal adhesion",smooth
1127,LGMD2B_B,GPRC5B,NA,52,"MAPK, pyruvate metabolism",smooth
1128,LGMD2B_B,RPS6KB1,-0.3,83,"propanoate metabolism, propanoate metabolism",skeletal
1129,LGMD2B_B,PSMA3,NA,76,"synthesis and degradation of ketone bodies, MAPK",smooth
1130,LGMD2B_B,JARID2,-0.2,81,"apoptosis, synthesis and degradation of ketone bodies",cardiac
1131,LGMD2B_B,ODF2,0.2,82,"apoptosis, pyruvate metabolism",cardiac
1132,LGMD2B_B,MON2,NA,14,"synthesis and degradation of ketone bodies, propanoate metabolism",smooth
1133,LGMD2B_B,PDLIM2,NA,96,"propanoate metabolism, propanoate metabolism",smooth
1134,LGMD2B_B,WAC,-0.2,19,"cancer pathways, MAPK",cardiac
1135,LGMD2B_B,FLCN,-0.1,30,"cancer pathways, cancer pathways",cardiac
1136,LGMD2B_B,ATF6,0.1,23,"Wnt signalling, synthesis and degradation of ketone bodies",cardiac
1137,LGMD2B_B,TRAFD1,-0.3,2,"synthesis and degradation of ketone bodies, synthesis and degradation of ketone bodies",smooth
1138,LGMD2B_B,BICD1,0.1,99,"cancer pathways, pyruvate metabolism",skeletal
1139,LGMD2B_B,ANP32A,0.1,14,"propanoate metabolism, Wnt signalling",smooth
1140,LGMD2B_B,KDSR,NA,100,"propanoate metabolism, synthesis and degradation of ketone bodies",skeletal
1141,LGMD2B_B,FBXO9,-0.2,11,"citrate cycle, Wnt signalling",smooth
1142,LGMD2B_B,UBQLN2,NA,26,"citrate cycle, propanoate metabolism",cardiac
1143,LGMD2B_B,ZFX,-0.1,51,"Wnt signalling, fatty acid degradation",skeletal
1144,LGMD2B_B,CPLX2,0.2,90,"fatty acid degradation, synthesis and degradation of ketone bodies",skeletal
1145,LGMD2B_B,CLPX,-0.3,11,"apoptosis, pyruvate metabolism",cardiac
1146,LGMD2B_B,SGCB,-0.3,45,"MAPK, pyruvate metabolism",smooth
1147,LGMD2B_B,SEMA5A,-0.2,20,"apoptosis, Wnt signalling",smooth
1148,LGMD2B_B,PTPRB,-0.3,87,"fatty acid degradation, fatty acid degradation",skeletal
1149,LGMD2B_B,TMEM33,0.1,37,"synthesis and degradation of ketone bodies, fatty acid degradation",cardiac
1150,LGMD2B_B,SMC1A,NA,74,"synthesis and degradation of ketone bodies, apoptosis",skeletal
1151,LGMD2I_B,NF1,NA,66,"citrate cycle, pyruvate metabolism",cardiac
1152,LGMD2I_B,UEVLD,0.1,20,"synthesis and degradation of ketone bodies, citrate cycle",smooth
1153,LGMD2I_B,CDC37L1,-0.1,11,"propanoate metabolism, synthesis and degradation of ketone bodies",cardiac
1154,LGMD2I_B,HOXD10,-0.1,70,"focal adhesion, synthesis and degradation of ketone bodies",skeletal
1155,LGMD2I_B,NNT,-0.6,44,"Wnt signalling, focal adhesion",skeletal
1156,LGMD2I_B,HUWE1,NA,41,"fatty acid degradation, propanoate metabolism",smooth
1157,LGMD2I_B,GJA5,0.3,73,"focal adhesion, citrate cycle",smooth
1158,LGMD2I_B,SPCS3,0.2,97,"cancer pathways, fatty acid degradation",cardiac
1159,LGMD2I_B,DOT1L,-0.1,80,"MAPK, apoptosis",smooth
1160,LGMD2I_B,ATP6V0E1,0.1,98,"apoptosis, MAPK",cardiac
1161,LGMD2I_B,XAF1,0.1,28,"synthesis and degradation of ketone bodies, pyruvate metabolism",cardiac
1162,LGMD2I_B,MAFG,0.2,56,"Wnt signalling, apoptosis",skeletal
1163,LGMD2I_B,AAK1,0.4,66,"apoptosis, focal adhesion",cardiac
1164,LGMD2I_B,TM2D3,NA,79,"apoptosis, synthesis and degradation of ketone bodies",cardiac
1165,LGMD2I_B,SSR3,NA,68,"pyruvate metabolism, Wnt signalling",cardiac
1166,LGMD2I_B,ZNF281,-0.3,13,"citrate cycle, synthesis and degradation of ketone bodies",smooth
1167,LGMD2I_B,JAM2,NA,38,"synthesis and degradation of ketone bodies, MAPK",smooth
1168,LGMD2I_B,CDC23,NA,54,"MAPK, Wnt signalling",cardiac
1169,LGMD2I_B,PLN,-0.3,57,"MAPK, apoptosis",skeletal
1170,LGMD2I_B,PGP,-0.4,29,"Wnt signalling, focal adhesion",cardiac
1171,LGMD2I_B,HYI,0.2,28,"citrate cycle, pyruvate metabolism",skeletal
1172,LGMD2I_B,IMPACT,-0.1,42,"citrate cycle, Wnt signalling",smooth
1173,LGMD2I_B,C2orf49,-0.2,36,"synthesis and degradation of ketone bodies, synthesis and degradation of ketone bodies",skeletal
1174,LGMD2I_B,HDAC11,-0.1,34,"apoptosis, propanoate metabolism",skeletal
1175,LGMD2I_B,CCN4,NA,62,"citrate cycle, apoptosis",cardiac
1176,LGMD2I_B,MKLN1,NA,25,"synthesis and degradation of ketone bodies, MAPK",skeletal
1177,LGMD2I_B,GPRC5B,0.1,71,"apoptosis, propanoate metabolism",smooth
1178,LGMD2I_B,RPS6KB1,-0.2,30,"synthesis and degradation of ketone bodies, apoptosis",cardiac
1179,LGMD2I_B,PSMA3,-0.1,75,"MAPK, fatty acid degradation",cardiac
1180,LGMD2I_B,JARID2,-0.2,84,"synthesis and degradation of ketone bodies, apoptosis",cardiac
1181,LGMD2I_B,ODF2,0.2,21,"propanoate metabolism, pyruvate metabolism",cardiac
1182,LGMD2I_B,MON2,-0.2,46,"apoptosis, MAPK",cardiac
1183,LGMD2I_B,PDLIM2,0.1,45,"propanoate metabolism, apoptosis",skeletal
1184,LGMD2I_B,WAC,0.1,9,"citrate cycle, synthesis and degradation of ketone bodies",cardiac
1185,LGMD2I_B,FLCN,-0.1,87,"Wnt signalling, fatty acid degradation",smooth
1186,LGMD2I_B,ATF6,0.2,54,"cancer pathways, apoptosis",cardiac
1187,LGMD2I_B,TRAFD1,-0.2,60,"propanoate metabolism, fatty acid degradation",skeletal
1188,LGMD2I_B,BICD1,0.3,91,"MAPK, cancer pathways",cardiac
1189,LGMD2I_B,ANP32A,NA,71,"synthesis and degradation of ketone bodies, synthesis and degradation of ketone bodies",smooth
1190,LGMD2I_B,KDSR,0.1,70,"citrate cycle, MAPK",skeletal
1191,LGMD2I_B,FBXO9,-0.2,77,"MAPK, citrate cycle",cardiac
1192,LGMD2I_B,UBQLN2,-0.2,94,"apoptosis, propanoate metabolism",cardiac
1193,LGMD2I_B,ZFX,NA,10,"apoptosis, synthesis and degradation of ketone bodies",skeletal
1194,LGMD2I_B,CPLX2,0.2,12,"Wnt signalling, Wnt signalling",smooth
1195,LGMD2I_B,CLPX,-0.3,26,"apoptosis, fatty acid degradation",smooth
1196,LGMD2I_B,SGCB,-0.1,45,"synthesis and degradation of ketone bodies, fatty acid degradation",smooth
1197,LGMD2I_B,SEMA5A,-0.2,22,"focal adhesion, Wnt signalling",skeletal
1198,LGMD2I_B,PTPRB,0.1,62,"MAPK, apoptosis",smooth
1199,LGMD2I_B,TMEM33,0.1,34,"pyruvate metabolism, pyruvate metabolism",cardiac
1200,LGMD2I_B,SMC1A,-0.2,89,"Wnt signalling, citrate cycle",skeletal